Home » Clinical Trials » Search Clinical Trials
Therapeutic Areas: Hematology | Trauma (Emergency, Injury, Surgery)
Clinical Trials: Hemorrhage
A listing of clinical trials currently looking for volunteers to enroll in Hemorrhage studies. Click on the closest city to find more detailed information on a research study in your area.
Alabama
Birmingham : The University of Alabama at Birmingham
Aspirin in Reducing Events in the Elderly
Birmingham : Nycomed Investigational Site
Comparison of Efficacy and Safety of TachoSil® Versus Surgicel® Original for the Secondary Hemostatic Treatment in Vascular Surgery
Birmingham : Cardio-Thoracic Surgeons, PC
Phase 3 Study of Fibrocaps™ in Surgical Bleeding
Birmingham : University of Alabama at Birmingham
Phase 3 Study of Fibrocaps™ in Surgical Bleeding
Birmingham :
Safety and Efficacy Study of Fibrin Sealant Grifols as an Adjunct to Hemostasis During Peripheral Vascular Surgery
Arizona
Phoenix : Novo Nordisk Clinical Trial Call Center
Evaluating the Haemostatic Effect of NNC 0129-0000-1003 During Surgical Procedures in Subjects With Haemophilia A
Phoenix : Novo Nordisk Clinical Trial Call Center
Evaluation of Safety and Efficacy, Including Pharmacokinetics, of NNC 0129-0000-1003 When Administered for Treatment and Prophylaxis of Bleeding in Subjects With Haemophilia A
Phoenix : Novo Nordisk Clinical Trial Call Center
Safety and Efficacy of NNC 0155-0000-0004 in Prevention and Treatment of Bleeds in Previously Untreated Children With Haemophilia A
Phoenix :
Safety and Efficacy Study of Fibrin Sealant Grifols as an Adjunct to Hemostasis During Peripheral Vascular Surgery
California
Loma Linda : Loma Linda University Medical Center
Effects of CoSeal on Bleeding & Adhesions in Pediatric Heart Surgery
Long Beach : Novo Nordisk Clinical Trial Call Center
Evaluating the Haemostatic Effect of NNC 0129-0000-1003 During Surgical Procedures in Subjects With Haemophilia A
Long Beach : Novo Nordisk Clinical Trial Call Center
Evaluation of Safety and Efficacy, Including Pharmacokinetics, of NNC 0129-0000-1003 When Administered for Treatment and Prophylaxis of Bleeding in Subjects With Haemophilia A
Los Angeles : Cedars-Sinai Medical Center
Clot Lysis: Evaluating Accelerated Resolution of Intraventricular Hemorrhage Phase III
Los Angeles : University of California Los Angeles
Clot Lysis: Evaluating Accelerated Resolution of Intraventricular Hemorrhage Phase III
View More »
Los Angeles : Nycomed Investigational Site
Comparison of Efficacy and Safety of TachoSil® Versus Surgicel® Original for the Secondary Hemostatic Treatment in Vascular Surgery
Los Angeles : Novo Nordisk Clinical Trial Call Center
Efficacy and Safety of NNC-0156-0000-0009 During Surgical Procedures in Subjects With Haemophilia B
Los Angeles : University of Southern California, Keck School of Medicine
Phase 3 Study of Fibrocaps™ in Surgical Bleeding
Los Angeles : University of Southern California/Norris Comprehensive Cancer Center
Phase 3 Study of Fibrocaps™ in Surgical Bleeding
Los Angeles : Novo Nordisk Clinical Trial Call Center
Safety and Efficacy of NNC-0156-0000-0009 After Long-Term Exposure in Patients With Haemophilia B: An Extension to Trials NN7999-3747 and NN7999-3773
Orange : Vascular Interventional Specialists of Orange County
Phase 3 Study of Fibrocaps™ in Surgical Bleeding
Palo Alto : Stanford University Medical Center
Adjunctive Application of BioFoam Surgical Matrix in Liver Surgery
Palo Alto : Stanford University
Clot Lysis: Evaluating Accelerated Resolution of Intraventricular Hemorrhage Phase III
Pasadna : Lotus Clinical Research, LLC
Phase 3 Study of Fibrocaps™ in Surgical Bleeding
Sacramento : Mercy General Sacramento
Clot Lysis: Evaluating Accelerated Resolution of Intraventricular Hemorrhage Phase III
Sacramento : Novo Nordisk Clinical Trial Call Center
Evaluating the Haemostatic Effect of NNC 0129-0000-1003 During Surgical Procedures in Subjects With Haemophilia A
Sacramento : Novo Nordisk Clinical Trial Call Center
Evaluation of Safety and Efficacy, Including Pharmacokinetics, of NNC 0129-0000-1003 When Administered for Treatment and Prophylaxis of Bleeding in Subjects With Haemophilia A
Sacramento : Research Site
Long-Term Safety and Efficacy of Recombinant Human Coagulation Factor IX Fusion Protein (rFIXFc) in the Prevention and Treatment of Bleeding Episodes in Previously Treated Subjects With Hemophilia B
Sacramento : Novo Nordisk Clinical Trial Call Center
Safety and Efficacy of NNC 0155-0000-0004 in Prevention and Treatment of Bleeds in Previously Untreated Children With Haemophilia A
San Francisco : Novo Nordisk Clinical Trial Call Center
Efficacy and Safety of NNC-0156-0000-0009 During Surgical Procedures in Subjects With Haemophilia B
Torrance : Novo Nordisk Clinical Trial Call Center
Evaluating the Haemostatic Effect of NNC 0129-0000-1003 During Surgical Procedures in Subjects With Haemophilia A
Torrance : Novo Nordisk Clinical Trial Call Center
Evaluation of Safety and Efficacy, Including Pharmacokinetics, of NNC 0129-0000-1003 When Administered for Treatment and Prophylaxis of Bleeding in Subjects With Haemophilia A
Colorado
Aurora : Research Site
Long-Term Safety and Efficacy of Recombinant Human Coagulation Factor IX Fusion Protein (rFIXFc) in the Prevention and Treatment of Bleeding Episodes in Previously Treated Subjects With Hemophilia B
Boulder : Boulder Neurological Institute
Phase 3 Study of Fibrocaps™ in Surgical Bleeding
Durango : Spine Colorado
Phase 3 Study of Fibrocaps™ in Surgical Bleeding
Connecticut
Hartford : Hartford Hospital
Clot Lysis: Evaluating Accelerated Resolution of Intraventricular Hemorrhage Phase III
New Haven : Yale University
Clot Lysis: Evaluating Accelerated Resolution of Intraventricular Hemorrhage Phase III
District of Columbia
Washington : Georgetown University Hospital
Albumin for Intracerebral Hemorrhage Intervention
Washington : Novo Nordisk Clinical Trial Call Center
Evaluation of Safety and Efficacy, Including Pharmacokinetics, of NNC 0129-0000-1003 When Administered for Treatment and Prophylaxis of Bleeding in Subjects With Haemophilia A
Washington : Novo Nordisk Clinical Trial Call Center
Safety and Efficacy of NNC 0155-0000-0004 in Prevention and Treatment of Bleeds in Previously Untreated Children With Haemophilia A
Washington :
Safety and Efficacy Study of Fibrin Sealant Grifols as an Adjunct to Hemostasis During Peripheral Vascular Surgery
Washington : Georgetown University
Wilate in Subjects With Von Willebrand Disease Who Undergo Major Surgery
View More »
Washington DC : Georgetown University
Clot Lysis: Evaluating Accelerated Resolution of Intraventricular Hemorrhage Phase III
Washington, DC : Novo Nordisk Clinical Trial Call Center
Efficacy and Safety of NNC-0156-0000-0009 During Surgical Procedures in Subjects With Haemophilia B
Washington, DC : Novo Nordisk Clinical Trial Call Center
Evaluating the Haemostatic Effect of NNC 0129-0000-1003 During Surgical Procedures in Subjects With Haemophilia A
Washington, DC : Novo Nordisk Clinical Trial Call Center
Evaluation of Safety and Efficacy, Including Pharmacokinetics, of NNC 0129-0000-1003 When Administered for Treatment and Prophylaxis of Bleeding in Subjects With Haemophilia A
Washington, DC : Novo Nordisk Clinical Trial Call Center
Safety and Efficacy of NNC-0156-0000-0009 After Long-Term Exposure in Patients With Haemophilia B: An Extension to Trials NN7999-3747 and NN7999-3773
Florida
Gainesville : Novo Nordisk Clinical Trial Call Center
Safety and Efficacy of NNC 0155-0000-0004 in Prevention and Treatment of Bleeds in Previously Untreated Children With Haemophilia A
Gainsville : University of Florida Department of Aging and Geriatrics
Aspirin in Reducing Events in the Elderly
Jacksonville : Mayo Clinic, Jacksonville
Clot Lysis: Evaluating Accelerated Resolution of Intraventricular Hemorrhage Phase III
Jacksonville : Novo Nordisk Clinical Trial Call Center
Safety and Efficacy of NNC-0156-0000-0009 After Long-Term Exposure in Patients With Haemophilia B: An Extension to Trials NN7999-3747 and NN7999-3773
Jacksonville : Baptist Health Medical Center
The Evicel Post-Authorization Surveillance Study
View More »
Miami : Novo Nordisk Clinical Trial Call Center
Evaluating the Haemostatic Effect of NNC 0129-0000-1003 During Surgical Procedures in Subjects With Haemophilia A
Miami : Novo Nordisk Clinical Trial Call Center
Evaluation of Safety and Efficacy, Including Pharmacokinetics, of NNC 0129-0000-1003 When Administered for Treatment and Prophylaxis of Bleeding in Subjects With Haemophilia A
Orlando : Novo Nordisk Clinical Trial Call Center
Evaluating the Haemostatic Effect of NNC 0129-0000-1003 During Surgical Procedures in Subjects With Haemophilia A
Orlando : Novo Nordisk Clinical Trial Call Center
Evaluation of Safety and Efficacy, Including Pharmacokinetics, of NNC 0129-0000-1003 When Administered for Treatment and Prophylaxis of Bleeding in Subjects With Haemophilia A
Orlando : Novo Nordisk Clinical Trial Call Center
Safety and Efficacy of NNC 0155-0000-0004 in Prevention and Treatment of Bleeds in Previously Untreated Children With Haemophilia A
Sarasota : Intercoastal Medical Center
Clot Lysis: Evaluating Accelerated Resolution of Intraventricular Hemorrhage Phase III
Tampa : University of South Florida
Clot Lysis: Evaluating Accelerated Resolution of Intraventricular Hemorrhage Phase III
Tampa : Novo Nordisk Clinical Trial Call Center
Evaluating the Haemostatic Effect of NNC 0129-0000-1003 During Surgical Procedures in Subjects With Haemophilia A
Tampa : Novo Nordisk Clinical Trial Call Center
Evaluation of Safety and Efficacy, Including Pharmacokinetics, of NNC 0129-0000-1003 When Administered for Treatment and Prophylaxis of Bleeding in Subjects With Haemophilia A
Tampa : Novo Nordisk Clinical Trial Call Center
Safety and Efficacy of NNC 0155-0000-0004 in Prevention and Treatment of Bleeds in Previously Untreated Children With Haemophilia A
Georgia
Augusta : Novo Nordisk Clinical Trial Call Center
Efficacy and Safety of NNC-0156-0000-0009 During Surgical Procedures in Subjects With Haemophilia B
Augusta : Novo Nordisk Clinical Trial Call Center
Evaluation of Safety and Efficacy, Including Pharmacokinetics, of NNC 0129-0000-1003 When Administered for Treatment and Prophylaxis of Bleeding in Subjects With Haemophilia A
Augusta : Novo Nordisk Clinical Trial Call Center
Safety and Efficacy of NNC 0155-0000-0004 in Prevention and Treatment of Bleeds in Previously Untreated Children With Haemophilia A
Augusta : Novo Nordisk Clinical Trial Call Center
Safety and Efficacy of NNC-0156-0000-0009 After Long-Term Exposure in Patients With Haemophilia B: An Extension to Trials NN7999-3747 and NN7999-3773
Augusta : Novo Nordisk Clinical Trial Call Center
Safety, Efficacy and Pharmacokinetics of NNC-0156-0000-0009 in Previously Treated Children With Haemophilia B
View More »
Austell : Nycomed Investigational Site
Comparison of Efficacy and Safety of TachoSil® Versus Surgicel® Original for the Secondary Hemostatic Treatment in Vascular Surgery
Idaho
Boise : Novo Nordisk Clinical Trial Call Center
Evaluating the Haemostatic Effect of NNC 0129-0000-1003 During Surgical Procedures in Subjects With Haemophilia A
Boise : Novo Nordisk Clinical Trial Call Center
Evaluation of Safety and Efficacy, Including Pharmacokinetics, of NNC 0129-0000-1003 When Administered for Treatment and Prophylaxis of Bleeding in Subjects With Haemophilia A
Illinois
Chicago : Rush Alzheimer's Disease Center
Aspirin in Reducing Events in the Elderly
Chicago : Rush University
Clot Lysis: Evaluating Accelerated Resolution of Intraventricular Hemorrhage Phase III
Chicago : University of Chicago
Clot Lysis: Evaluating Accelerated Resolution of Intraventricular Hemorrhage Phase III
Chicago : University of Illinois at Chicago
Clot Lysis: Evaluating Accelerated Resolution of Intraventricular Hemorrhage Phase III
Chicago : Northwestern University
Phase 3 Study of Fibrocaps™ in Surgical Bleeding
View More »
Oak Lawn : Novo Nordisk Clinical Trial Call Center
Safety and Efficacy of NNC 0155-0000-0004 in Prevention and Treatment of Bleeds in Previously Untreated Children With Haemophilia A
Peoria : OSF Stroke Center
IV Double and Triple Concentrated Nicardipine for Stroke and ICH
Peoria : University of Illinois College of Medicine at Peoria
Pharmacokinetics, Safety and Efficacy of Recombinant Von Willebrand Factor (rVWF) in the Treatment of Bleeding Episodes in Von Willebrand Disease (VWD)
Skokie : NorthShore University HealthSystem
Phase 3 Study of Fibrocaps™ in Surgical Bleeding
Springfield : Nycomed Investigational Site
Comparison of Efficacy and Safety of TachoSil® Versus Surgicel® Original for the Secondary Hemostatic Treatment in Vascular Surgery
Springfield : Southern Illinois University School of Medicine
Phase 3 Study of Fibrocaps™ in Surgical Bleeding
Springfield :
Safety and Efficacy Study of Fibrin Sealant Grifols as an Adjunct to Hemostasis During Peripheral Vascular Surgery
Indiana
Carmel : Indiana Spine Group
Phase 3 Study of Fibrocaps™ in Surgical Bleeding
Indianapolis : Research Site
Long-Term Safety and Efficacy of Recombinant Human Coagulation Factor IX Fusion Protein (rFIXFc) in the Prevention and Treatment of Bleeding Episodes in Previously Treated Subjects With Hemophilia B
Indianapolis : Indiana Hemophilia and Thrombosis Center
Pharmacokinetics, Safety and Efficacy of Recombinant Von Willebrand Factor (rVWF) in the Treatment of Bleeding Episodes in Von Willebrand Disease (VWD)
Iowa
Iowa City : University of Iowa
Aspirin in Reducing Events in the Elderly
Iowa City : University of Iowa
Clot Lysis: Evaluating Accelerated Resolution of Intraventricular Hemorrhage Phase III
Iowa City : Novo Nordisk Clinical Trial Call Center
Efficacy and Safety of NNC-0156-0000-0009 During Surgical Procedures in Subjects With Haemophilia B
Iowa City : Novo Nordisk Clinical Trial Call Center
Evaluating the Haemostatic Effect of NNC 0129-0000-1003 During Surgical Procedures in Subjects With Haemophilia A
Iowa City : Novo Nordisk Clinical Trial Call Center
Evaluation of Safety and Efficacy, Including Pharmacokinetics, of NNC 0129-0000-1003 When Administered for Treatment and Prophylaxis of Bleeding in Subjects With Haemophilia A
View More »
Iowa City : Novo Nordisk Clinical Trial Call Center
Safety and Efficacy of NNC-0156-0000-0009 After Long-Term Exposure in Patients With Haemophilia B: An Extension to Trials NN7999-3747 and NN7999-3773
Iowa City :
Safety and Efficacy Study of Fibrin Sealant Grifols as an Adjunct to Hemostasis During Peripheral Vascular Surgery
Kentucky
Lexington : Nycomed Investigational Site
Comparison of Efficacy and Safety of TachoSil® Versus Surgicel® Original for the Secondary Hemostatic Treatment in Vascular Surgery
Lexington : Bluegrass Orthopedics
Phase 3 Study of Fibrocaps™ in Surgical Bleeding
Lexington :
Safety and Efficacy of Fibrin Sealant Grifols (FS Grifols) During Parenchymous Tissue Open Surgeries
Lexington :
Safety and Efficacy Study of Fibrin Sealant Grifols as an Adjunct to Hemostasis During Peripheral Vascular Surgery
Louisville : Jewish Hospital
Enteral Nutrition as Stress Ulcer Prophylaxis in Critically Ill Patients.
Louisiana
New Orleans : Novo Nordisk Clinical Trial Call Center
Evaluating the Haemostatic Effect of NNC 0129-0000-1003 During Surgical Procedures in Subjects With Haemophilia A
New Orleans : Novo Nordisk Clinical Trial Call Center
Evaluation of Safety and Efficacy, Including Pharmacokinetics, of NNC 0129-0000-1003 When Administered for Treatment and Prophylaxis of Bleeding in Subjects With Haemophilia A
Maryland
Baltimore : Johns Hopkins University
Clot Lysis: Evaluating Accelerated Resolution of Intraventricular Hemorrhage Phase III
Baltimore : University of Maryland
Clot Lysis: Evaluating Accelerated Resolution of Intraventricular Hemorrhage Phase III
Baltimore : Novo Nordisk Clinical Trial Call Center
Evaluating the Haemostatic Effect of NNC 0129-0000-1003 During Surgical Procedures in Subjects With Haemophilia A
Baltimore : Novo Nordisk Clinical Trial Call Center
Evaluation of Safety and Efficacy, Including Pharmacokinetics, of NNC 0129-0000-1003 When Administered for Treatment and Prophylaxis of Bleeding in Subjects With Haemophilia A
Baltimore : Johns Hopkins University
Phase II Clinical Trial on Treatment of Intraventricular Hemorrhage
View More »
Baltimore : University of Maryland Medical Systems
Phase II Clinical Trial on Treatment of Intraventricular Hemorrhage
Baltimore : Novo Nordisk Clinical Trial Call Center
Safety and Efficacy of NNC-0156-0000-0009 After Long-Term Exposure in Patients With Haemophilia B: An Extension to Trials NN7999-3747 and NN7999-3773
Randallstown : Northwest Hospital
Intrauterine Use of FloSeal: Is it Safe and Useful?
Massachusetts
Boston : Massachusetts General Hospital
Clot Lysis: Evaluating Accelerated Resolution of Intraventricular Hemorrhage Phase III
Boston : Novo Nordisk Clinical Trial Call Center
Evaluating the Haemostatic Effect of NNC 0129-0000-1003 During Surgical Procedures in Subjects With Haemophilia A
Boston : Novo Nordisk Clinical Trial Call Center
Evaluation of Safety and Efficacy, Including Pharmacokinetics, of NNC 0129-0000-1003 When Administered for Treatment and Prophylaxis of Bleeding in Subjects With Haemophilia A
Boston : Massachusetts General Hospital
Pilot Study of Model Based Iterative Reconstruction Using 64-Slice
Burlington : Lahey Clinic Medical Center
Phase 3 Study of Fibrocaps™ in Surgical Bleeding
Michigan
Detroit : Wayne State University
Aspirin in Reducing Events in the Elderly
Detroit : Henry Ford Health System
Aspirin in Reducing Events in the Elderly
Detroit : Henry Ford Health System
Clot Lysis: Evaluating Accelerated Resolution of Intraventricular Hemorrhage Phase III
Detroit : Novo Nordisk Clinical Trial Call Center
Evaluating the Haemostatic Effect of NNC 0129-0000-1003 During Surgical Procedures in Subjects With Haemophilia A
Detroit : Novo Nordisk Clinical Trial Call Center
Evaluation of Safety and Efficacy, Including Pharmacokinetics, of NNC 0129-0000-1003 When Administered for Treatment and Prophylaxis of Bleeding in Subjects With Haemophilia A
View More »
Detroit : Wayne State University
Phase II Clinical Trial on Treatment of Intraventricular Hemorrhage
Detroit : Novo Nordisk Clinical Trial Call Center
Safety and Efficacy of NNC 0155-0000-0004 in Prevention and Treatment of Bleeds in Previously Untreated Children With Haemophilia A
Detroit : Henry Ford Hospital
Safety and Efficacy Study of Clevidipine to Control Hypertension in Patients Admitted With Aneurysmal Subarachnoid Hemorrhage
Detroit : Henry Ford Health System
Wilate in Subjects With Von Willebrand Disease Who Undergo Major Surgery
East Lansing : Novo Nordisk Clinical Trial Call Center
Evaluating the Haemostatic Effect of NNC 0129-0000-1003 During Surgical Procedures in Subjects With Haemophilia A
East Lansing : Novo Nordisk Clinical Trial Call Center
Evaluation of Safety and Efficacy, Including Pharmacokinetics, of NNC 0129-0000-1003 When Administered for Treatment and Prophylaxis of Bleeding in Subjects With Haemophilia A
Kalamazoo : Borgess Research Institute
Phase 3 Study of Fibrocaps™ in Surgical Bleeding
Royal Oak : Beaumont Health System
Phase 3 Study of Fibrocaps™ in Surgical Bleeding
Minnesota
Minneapolis : Health Partners Research Foundation
Aspirin in Reducing Events in the Elderly
Minneapolis : Novo Nordisk Clinical Trial Call Center
Evaluation of Safety and Efficacy, Including Pharmacokinetics, of NNC 0129-0000-1003 When Administered for Treatment and Prophylaxis of Bleeding in Subjects With Haemophilia A
Minneapolis : Novo Nordisk Clinical Trial Call Center
Safety and Efficacy of NNC-0156-0000-0009 After Long-Term Exposure in Patients With Haemophilia B: An Extension to Trials NN7999-3747 and NN7999-3773
Minneapolis : Novo Nordisk Clinical Trial Call Center
Safety, Efficacy and Pharmacokinetics of NNC-0156-0000-0009 in Previously Treated Children With Haemophilia B
St. Paul : Phalen Village Clinic
Aspirin in Reducing Events in the Elderly
Missouri
Springfield : Springfield Neurological and Spine Institute
Clot Lysis: Evaluating Accelerated Resolution of Intraventricular Hemorrhage Phase III
St. Louis : St. Louis University
Clot Lysis: Evaluating Accelerated Resolution of Intraventricular Hemorrhage Phase III
St. Louis : Washington University School of Medicine
Phase 3 Study of Fibrocaps™ in Surgical Bleeding
Nebraska
Omaha : Novo Nordisk Clinical Trial Call Center
Evaluation of Safety and Efficacy, Including Pharmacokinetics, of NNC 0129-0000-1003 When Administered for Treatment and Prophylaxis of Bleeding in Subjects With Haemophilia A
Omaha : Novo Nordisk Clinical Trial Call Center
Safety and Efficacy of NNC-0156-0000-0009 After Long-Term Exposure in Patients With Haemophilia B: An Extension to Trials NN7999-3747 and NN7999-3773
Nevada
Las Vegas : William Muir MD Spine Surgery
Phase 3 Study of Fibrocaps™ in Surgical Bleeding
Las Vegas : Novo Nordisk Clinical Trial Call Center
Safety and Efficacy of NNC 0155-0000-0004 in Prevention and Treatment of Bleeds in Previously Untreated Children With Haemophilia A
New Jersey
Camden : Cooper University Hospital
Clot Lysis: Evaluating Accelerated Resolution of Intraventricular Hemorrhage Phase III
Edison : New Jersey Neuroscience Institute at JFK
Clot Lysis: Evaluating Accelerated Resolution of Intraventricular Hemorrhage Phase III
New Brunswick : Novo Nordisk Clinical Trial Call Center
Evaluating the Haemostatic Effect of NNC 0129-0000-1003 During Surgical Procedures in Subjects With Haemophilia A
New Brunswick : Novo Nordisk Clinical Trial Call Center
Evaluation of Safety and Efficacy, Including Pharmacokinetics, of NNC 0129-0000-1003 When Administered for Treatment and Prophylaxis of Bleeding in Subjects With Haemophilia A
New Brunswick : Novo Nordisk Clinical Trial Call Center
Safety and Efficacy of NNC 0155-0000-0004 in Prevention and Treatment of Bleeds in Previously Untreated Children With Haemophilia A
View More »
Newark : Novo Nordisk Clinical Trial Call Center
Evaluating the Haemostatic Effect of NNC 0129-0000-1003 During Surgical Procedures in Subjects With Haemophilia A
Newark : Novo Nordisk Clinical Trial Call Center
Evaluation of Safety and Efficacy, Including Pharmacokinetics, of NNC 0129-0000-1003 When Administered for Treatment and Prophylaxis of Bleeding in Subjects With Haemophilia A
Newark : Newark Beth Israel Medical Center
Pharmacokinetics, Safety and Efficacy of Recombinant Von Willebrand Factor (rVWF) in the Treatment of Bleeding Episodes in Von Willebrand Disease (VWD)
Newark : Novo Nordisk Clinical Trial Call Center
Safety and Efficacy of NNC-0156-0000-0009 After Long-Term Exposure in Patients With Haemophilia B: An Extension to Trials NN7999-3747 and NN7999-3773
New Mexico
Albuquerque : Lovelace Clinic Foundation
Aspirin in Reducing Events in the Elderly
New York
Brooklyn : Novo Nordisk Clinical Trial Call Center
Safety and Efficacy of NNC 0155-0000-0004 in Prevention and Treatment of Bleeds in Previously Untreated Children With Haemophilia A
Buffalo : University of Buffalo
Clot Lysis: Evaluating Accelerated Resolution of Intraventricular Hemorrhage Phase III
Manhasset : Northshore University Hospital Long Island
Clot Lysis: Evaluating Accelerated Resolution of Intraventricular Hemorrhage Phase III
New York : Columbia University Medical Center
Aggressive Fever Control With Intravenous Ibuprofen After Non-traumatic Brain Hemorrhage
New York : Columbia University
Clot Lysis: Evaluating Accelerated Resolution of Intraventricular Hemorrhage Phase III
View More »
New York : Mount Sinai Hospital
Clot Lysis: Evaluating Accelerated Resolution of Intraventricular Hemorrhage Phase III
New York : Nycomed Investigational Site
Comparison of Efficacy and Safety of TachoSil® Versus Surgicel® Original for the Secondary Hemostatic Treatment in Vascular Surgery
New York : Novo Nordisk Clinical Trial Call Center
Evaluating the Haemostatic Effect of NNC 0129-0000-1003 During Surgical Procedures in Subjects With Haemophilia A
New York : Mt. Sinai Medical Center
Phase II Clinical Trial on Treatment of Intraventricular Hemorrhage
New York : Novo Nordisk Clinical Trial Call Center
Safety and Efficacy of NNC-0156-0000-0009 After Long-Term Exposure in Patients With Haemophilia B: An Extension to Trials NN7999-3747 and NN7999-3773
New York : Novo Nordisk Clinical Trial Call Center
Safety, Efficacy and Pharmacokinetics of NNC-0156-0000-0009 in Previously Treated Children With Haemophilia B
New York City : New York-Presbyterian Hospital/Columbia University
Phase 3 Study of Fibrocaps™ in Surgical Bleeding
Rochester : The Mary M Gooley Hemophilia Center and Rochester General Hospital
Pharmacokinetics, Safety and Efficacy of Recombinant Von Willebrand Factor (rVWF) in the Treatment of Bleeding Episodes in Von Willebrand Disease (VWD)
Rochester : Mary M Gooley Hemophilia Center
Wilate in Subjects With Von Willebrand Disease Who Undergo Major Surgery
Staten Island : Staten Island University Hosptial
Randomized Double Blind Control Trial on Effects of Ranolazine on New Onset Atrial Fibrillation
Syracuse : SUNY Upstate Medical Center
Clot Lysis: Evaluating Accelerated Resolution of Intraventricular Hemorrhage Phase III
Syracuse : Novo Nordisk Clinical Trial Call Center
Efficacy and Safety of NNC-0156-0000-0009 During Surgical Procedures in Subjects With Haemophilia B
Syracuse : Novo Nordisk Clinical Trial Call Center
Safety and Efficacy of NNC-0156-0000-0009 After Long-Term Exposure in Patients With Haemophilia B: An Extension to Trials NN7999-3747 and NN7999-3773
Valhalla : Novo Nordisk Clinical Trial Call Center
Safety and Efficacy of NNC 0155-0000-0004 in Prevention and Treatment of Bleeds in Previously Untreated Children With Haemophilia A
Valhalla : Novo Nordisk Clinical Trial Call Center
Safety and Efficacy of NNC-0156-0000-0009 After Long-Term Exposure in Patients With Haemophilia B: An Extension to Trials NN7999-3747 and NN7999-3773
North Carolina
Chapel Hill : University of North Carolina Chapel Hill
Aspirin in Reducing Events in the Elderly
Chapel Hill : The University of North Carolina at Chapel Hill
Lovaza's Effect on the Activation of Platelets
Chapel Hill : University of North Carolina at Chapel Hill
Pharmacokinetics, Safety and Efficacy of Recombinant Von Willebrand Factor (rVWF) in the Treatment of Bleeding Episodes in Von Willebrand Disease (VWD)
Charlotte : Novo Nordisk Clinical Trial Call Center
Safety and Efficacy of NNC 0155-0000-0004 in Prevention and Treatment of Bleeds in Previously Untreated Children With Haemophilia A
Durham : Duke University Hospital Medical Center
Phase 3 Study of Fibrocaps™ in Surgical Bleeding
View More »
Durham : Duke University Medical Center
Pilot Study of Model Based Iterative Reconstruction Using 64-Slice
Greensboro : Wake Forest University Baptist Medical Center
Aspirin in Reducing Events in the Elderly
Winston-Salem : Wake Forest University Baptist Medical Center
Aspirin in Reducing Events in the Elderly
Winston-Salem : Wake Forest School of Medicine
Aspirin in Reducing Events in the Elderly
Winston-Salem : Wake Forest University
Clot Lysis: Evaluating Accelerated Resolution of Intraventricular Hemorrhage Phase III
Ohio
Cincinnati : University of Cincinnati
Clot Lysis: Evaluating Accelerated Resolution of Intraventricular Hemorrhage Phase III
Cincinnati : Novo Nordisk Clinical Trial Call Center
Evaluating the Haemostatic Effect of NNC 0129-0000-1003 During Surgical Procedures in Subjects With Haemophilia A
Cincinnati : Novo Nordisk Clinical Trial Call Center
Evaluation of Safety and Efficacy, Including Pharmacokinetics, of NNC 0129-0000-1003 When Administered for Treatment and Prophylaxis of Bleeding in Subjects With Haemophilia A
Cincinnati : University of Cincinnati
Phase II Clinical Trial on Treatment of Intraventricular Hemorrhage
Cincinnati : Novo Nordisk Clinical Trial Call Center
Safety and Efficacy of NNC 0155-0000-0004 in Prevention and Treatment of Bleeds in Previously Untreated Children With Haemophilia A
View More »
Cleveland : Case-Western Reserve University Hospital
Clot Lysis: Evaluating Accelerated Resolution of Intraventricular Hemorrhage Phase III
Cleveland : Cleveland Clinic Foundation
Phase 3 Study of Fibrocaps™ in Surgical Bleeding
Cleveland : Cleveland Clinic Foundation
Secondary Prophylaxis of Gastrointestinal Bleeding in Cirrhotic Patients Using THALIDOMIDE
Dayton : Novo Nordisk Clinical Trial Call Center
Evaluation of Safety and Efficacy, Including Pharmacokinetics, of NNC 0129-0000-1003 When Administered for Treatment and Prophylaxis of Bleeding in Subjects With Haemophilia A
Toledo :
Safety and Efficacy Study of Fibrin Sealant Grifols as an Adjunct to Hemostasis During Peripheral Vascular Surgery
Oklahoma
Tulsa : The University of Oklahoma - Tulsa
Phase 3 Study of Fibrocaps™ in Surgical Bleeding
Oregon
Portland : Providence Stroke Center
Clot Lysis: Evaluating Accelerated Resolution of Intraventricular Hemorrhage Phase III
Portland : Novo Nordisk Clinical Trial Call Center
Evaluating the Haemostatic Effect of NNC 0129-0000-1003 During Surgical Procedures in Subjects With Haemophilia A
Portland : Novo Nordisk Clinical Trial Call Center
Evaluation of Safety and Efficacy, Including Pharmacokinetics, of NNC 0129-0000-1003 When Administered for Treatment and Prophylaxis of Bleeding in Subjects With Haemophilia A
Portland : Oregon Health & Science University Hospital & Clinics
Phase 3 Study of Fibrocaps™ in Surgical Bleeding
Portland : Novo Nordisk Clinical Trial Call Center
Safety and Efficacy of NNC 0155-0000-0004 in Prevention and Treatment of Bleeds in Previously Untreated Children With Haemophilia A
Pennsylvania
Hershey : Penn State Hershey Medical Center
Clot Lysis: Evaluating Accelerated Resolution of Intraventricular Hemorrhage Phase III
Monroeville :
Safety and Efficacy Study of Fibrin Sealant Grifols as an Adjunct to Hemostasis During Peripheral Vascular Surgery
Philadelphia : Temple University Hospital
Clot Lysis: Evaluating Accelerated Resolution of Intraventricular Hemorrhage Phase III
Philadelphia : Albert Einstein Medical Center
Clot Lysis: Evaluating Accelerated Resolution of Intraventricular Hemorrhage Phase III
Philadelphia : Thomas Jefferson University Hospital
Clot Lysis: Evaluating Accelerated Resolution of Intraventricular Hemorrhage Phase III
View More »
Philadelphia : Novo Nordisk Clinical Trial Call Center
Evaluating the Haemostatic Effect of NNC 0129-0000-1003 During Surgical Procedures in Subjects With Haemophilia A
Philadelphia : Novo Nordisk Clinical Trial Call Center
Evaluation of Safety and Efficacy, Including Pharmacokinetics, of NNC 0129-0000-1003 When Administered for Treatment and Prophylaxis of Bleeding in Subjects With Haemophilia A
Philadelphia : Pennsylvania Hospital
Pharmacokinetics, Safety and Efficacy of Recombinant Von Willebrand Factor (rVWF) in the Treatment of Bleeding Episodes in Von Willebrand Disease (VWD)
Pittsburg :
Safety and Efficacy of Fibrin Sealant Grifols (FS Grifols) During Soft Tissue Open Surgeries
Pittsburgh : University of Pittsburgh Health Sciences Research Center
Aspirin in Reducing Events in the Elderly
Pittsburgh : Allegheny General Hospital
Clot Lysis: Evaluating Accelerated Resolution of Intraventricular Hemorrhage Phase III
Pittsburgh : University of Pittsburgh Medical Center
Clot Lysis: Evaluating Accelerated Resolution of Intraventricular Hemorrhage Phase III
Pittsburgh : Research Site
Long-Term Safety and Efficacy of Recombinant Human Coagulation Factor IX Fusion Protein (rFIXFc) in the Prevention and Treatment of Bleeding Episodes in Previously Treated Subjects With Hemophilia B
Pittsburgh : Hemophilia Center of Western Pennsylvania
Pharmacokinetics, Safety and Efficacy of Recombinant Von Willebrand Factor (rVWF) in the Treatment of Bleeding Episodes in Von Willebrand Disease (VWD)
Pittsburgh : UPMC-Presbyterian Hospital
Pre-emptive Hemodynamic Optimization of High Risk Patients Undergoing Elective Major Surgical Procedures
Pittsburgh :
Safety and Efficacy Study of Fibrin Sealant Grifols as an Adjunct to Hemostasis During Peripheral Vascular Surgery
South Carolina
Charleston : Medical University of South Carolina
Clot Lysis: Evaluating Accelerated Resolution of Intraventricular Hemorrhage Phase III
Charleston : Novo Nordisk Clinical Trial Call Center
Evaluating the Haemostatic Effect of NNC 0129-0000-1003 During Surgical Procedures in Subjects With Haemophilia A
Charleston : Novo Nordisk Clinical Trial Call Center
Evaluation of Safety and Efficacy, Including Pharmacokinetics, of NNC 0129-0000-1003 When Administered for Treatment and Prophylaxis of Bleeding in Subjects With Haemophilia A
Charleston : Medical University of South Carolina
Phase II Clinical Trial on Treatment of Intraventricular Hemorrhage
Charleston : Novo Nordisk Clinical Trial Call Center
Safety and Efficacy of NNC 0155-0000-0004 in Prevention and Treatment of Bleeds in Previously Untreated Children With Haemophilia A
Tennessee
Memphis : Methodist Healthcare, University Hospital
The Efficacy and Safety of Cleviprex in Ventriculostomy Patients Requiring IV Antihypertensive Therapy
Nashville : Novo Nordisk Clinical Trial Call Center
Evaluating the Haemostatic Effect of NNC 0129-0000-1003 During Surgical Procedures in Subjects With Haemophilia A
Nashville : Novo Nordisk Clinical Trial Call Center
Evaluation of Safety and Efficacy, Including Pharmacokinetics, of NNC 0129-0000-1003 When Administered for Treatment and Prophylaxis of Bleeding in Subjects With Haemophilia A
Nashville : Novo Nordisk Clinical Trial Call Center
Safety, Efficacy and Pharmacokinetics of NNC-0156-0000-0009 in Previously Treated Children With Haemophilia B
Texas
Dallas : University of Texas Southwestern Medical Center at Dallas
Aspirin in Reducing Events in the Elderly
Dallas : University of Texas, Southwestern, Dallas
Clot Lysis: Evaluating Accelerated Resolution of Intraventricular Hemorrhage Phase III
Fort Worth : University of North Texas Health Sciences Center
Phase 3 Study of Fibrocaps™ in Surgical Bleeding
Galveston : Nycomed Investigational Site
Comparison of Efficacy and Safety of TachoSil® Versus Surgicel® Original for the Secondary Hemostatic Treatment in Vascular Surgery
Houston : University of Texas, Houston
Clot Lysis: Evaluating Accelerated Resolution of Intraventricular Hemorrhage Phase III
View More »
Houston : Nycomed Investigational Site
Comparison of Efficacy and Safety of TachoSil® Versus Surgicel® Original for the Secondary Hemostatic Treatment in Vascular Surgery
Houston : Novo Nordisk Clinical Trial Call Center
Efficacy and Safety of NNC-0156-0000-0009 During Surgical Procedures in Subjects With Haemophilia B
Houston : Novo Nordisk Clinical Trial Call Center
Evaluating the Haemostatic Effect of NNC 0129-0000-1003 During Surgical Procedures in Subjects With Haemophilia A
Houston : Novo Nordisk Clinical Trial Call Center
Evaluation of Safety and Efficacy, Including Pharmacokinetics, of NNC 0129-0000-1003 When Administered for Treatment and Prophylaxis of Bleeding in Subjects With Haemophilia A
Houston :
Safety and Efficacy of Fibrin Sealant Grifols (FS Grifols) During Soft Tissue Open Surgeries
Houston : Novo Nordisk Clinical Trial Call Center
Safety and Efficacy of NNC-0156-0000-0009 After Long-Term Exposure in Patients With Haemophilia B: An Extension to Trials NN7999-3747 and NN7999-3773
Houston :
Safety and Efficacy Study of Fibrin Sealant Grifols as an Adjunct to Hemostasis During Peripheral Vascular Surgery
Houston : Novo Nordisk Clinical Trial Call Center
Safety, Efficacy and Pharmacokinetics of NNC-0156-0000-0009 in Previously Treated Children With Haemophilia B
Houston : Gulph States Hemophilia and Thrombophilia Center
Wilate in Subjects With Von Willebrand Disease Who Undergo Major Surgery
McAllen : South Texas College
Aspirin in Reducing Events in the Elderly
McKinney :
Safety and Efficacy Study of Fibrin Sealant Grifols as an Adjunct to Hemostasis During Peripheral Vascular Surgery
San Antonio : UT Health Science Center at San Antonio
Aspirin in Reducing Events in the Elderly
San Antonio : University of Texas, San Antonio
Clot Lysis: Evaluating Accelerated Resolution of Intraventricular Hemorrhage Phase III
Utah
Salt Lake City : University of Utah
Clot Lysis: Evaluating Accelerated Resolution of Intraventricular Hemorrhage Phase III
Sandy : Physician's Research Options
Phase 3 Study of Fibrocaps™ in Surgical Bleeding
Virginia
Charlottesville : Novo Nordisk Clinical Trial Call Center
Evaluation of Safety and Efficacy, Including Pharmacokinetics, of NNC 0129-0000-1003 When Administered for Treatment and Prophylaxis of Bleeding in Subjects With Haemophilia A
Charlottesville : Novo Nordisk Clinical Trial Call Center
Safety and Efficacy of NNC 0155-0000-0004 in Prevention and Treatment of Bleeds in Previously Untreated Children With Haemophilia A
Charlottesville : University of Virginia Health System Medical Center
Safety and Pharmacokinetic Evaluation of Nitrite for Prevention of Cerebral Vasospasm
Norfolk : Novo Nordisk Clinical Trial Call Center
Evaluation of Safety and Efficacy, Including Pharmacokinetics, of NNC 0129-0000-1003 When Administered for Treatment and Prophylaxis of Bleeding in Subjects With Haemophilia A
Richmond : Virginia Commonwealth University
Clot Lysis: Evaluating Accelerated Resolution of Intraventricular Hemorrhage Phase III
View More »
Richmond : Virginia Commonwealth University
Phase II Clinical Trial on Treatment of Intraventricular Hemorrhage
Washington
Bellevue : Nycomed Investigational Site
Comparison of Efficacy and Safety of TachoSil® Versus Surgicel® Original for the Secondary Hemostatic Treatment in Vascular Surgery
Bellevue : Overlake Hospital Medical Center
Phase 3 Study of Fibrocaps™ in Surgical Bleeding
Olympia : Novo Nordisk Clinical Trial Call Center
Safety and Efficacy of NNC-0156-0000-0009 After Long-Term Exposure in Patients With Haemophilia B: An Extension to Trials NN7999-3747 and NN7999-3773
Seattle : Swedish Medical Center
Clot Lysis: Evaluating Accelerated Resolution of Intraventricular Hemorrhage Phase III
Seattle : Research Site
Long-Term Safety and Efficacy of Recombinant Human Coagulation Factor IX Fusion Protein (rFIXFc) in the Prevention and Treatment of Bleeding Episodes in Previously Treated Subjects With Hemophilia B
View More »
Seattle : Virginia Mason Medical Center
Phase 3 Study of Fibrocaps™ in Surgical Bleeding
Spokane : Novo Nordisk Clinical Trial Call Center
Evaluating the Haemostatic Effect of NNC 0129-0000-1003 During Surgical Procedures in Subjects With Haemophilia A
Spokane : Novo Nordisk Clinical Trial Call Center
Evaluation of Safety and Efficacy, Including Pharmacokinetics, of NNC 0129-0000-1003 When Administered for Treatment and Prophylaxis of Bleeding in Subjects With Haemophilia A
Spokane : Northwest Orthopaedic Specialists, P.S.
Phase 3 Study of Fibrocaps™ in Surgical Bleeding
Tacoma : Multicare Neuroscience Center of Washington
Phase 3 Study of Fibrocaps™ in Surgical Bleeding
Wisconsin
Milwaukee : Children's Hospital of Wisconsin
Antithrombin III Supplementation for Cardiopulmonary Bypass in Neonates
Milwaukee : Medical College of Wisconsin
Clot Lysis: Evaluating Accelerated Resolution of Intraventricular Hemorrhage Phase III
Milwaukee : Blood Center of Wisconsin
Pharmacokinetics, Safety and Efficacy of Recombinant Von Willebrand Factor (rVWF) in the Treatment of Bleeding Episodes in Von Willebrand Disease (VWD)
Miwaukee : Froedtert Memorial Lutheran Hospital
Pilot Study of Model Based Iterative Reconstruction Using 64-Slice
Australia
Adelaide : Research Site
Long-Term Safety and Efficacy of Recombinant Human Coagulation Factor IX Fusion Protein (rFIXFc) in the Prevention and Treatment of Bleeding Episodes in Previously Treated Subjects With Hemophilia B
Adelaide : Royal Adelaide Hospital
Pharmacokinetics, Safety and Efficacy of Recombinant Von Willebrand Factor (rVWF) in the Treatment of Bleeding Episodes in Von Willebrand Disease (VWD)
Parkville :
Evaluation of Safety and Efficacy, Including Pharmacokinetics, of NNC 0129-0000-1003 When Administered for Treatment and Prophylaxis of Bleeding in Subjects With Haemophilia A
Perth : Research Site
Long-Term Safety and Efficacy of Recombinant Human Coagulation Factor IX Fusion Protein (rFIXFc) in the Prevention and Treatment of Bleeding Episodes in Previously Treated Subjects With Hemophilia B
Perth : Royal Perth Hospital
Pharmacokinetics, Safety and Efficacy of Recombinant Von Willebrand Factor (rVWF) in the Treatment of Bleeding Episodes in Von Willebrand Disease (VWD)
Austria
Graz :
Safety and Efficacy of NNC 0155-0000-0004 in Prevention and Treatment of Bleeds in Previously Untreated Children With Haemophilia A
Vienna : Medical University Vienna
Pharmacokinetics, Safety and Efficacy of Recombinant Von Willebrand Factor (rVWF) in the Treatment of Bleeding Episodes in Von Willebrand Disease (VWD)
Vienna : Allgemeines Krankenhaus der Stadt Wien - Universitätskliniken
Study of Fibrinogen Concentrate (Human) (FCH) to Control Bleeding During Complex Cardiovascular Surgery
Belgium
Bonheiden :
A Premarket, Prospective, Randomized, Single-Blind Study to Compare the Veriset™ Hemostatic Patch to TachoSil® as an Adjunct to Hemostasis in Subjects Undergoing Cardiovascular Surgery
Brussells : Militair Hospitaal Koningin Astrid
Phase 3 Study of Fibrocaps™ in Surgical Bleeding
Brussels :
A Premarket, Prospective, Randomized, Single-Blind Study to Compare the Veriset™ Hemostatic Patch to TachoSil® as an Adjunct to Hemostasis in Subjects Undergoing Cardiovascular Surgery
Bruxelles : Research Site
Long-Term Safety and Efficacy of Recombinant Human Coagulation Factor IX Fusion Protein (rFIXFc) in the Prevention and Treatment of Bleeding Episodes in Previously Treated Subjects With Hemophilia B
Bruxelles : Cliniques Universitaires Saint-Luc
Pharmacokinetics, Safety and Efficacy of Recombinant Von Willebrand Factor (rVWF) in the Treatment of Bleeding Episodes in Von Willebrand Disease (VWD)
View More »
Bruxelles : Hopital Erasme, Service de Neurochirurgie
Phase 3 Study of Fibrocaps™ in Surgical Bleeding
Bruxelles : Clinique du Parc Leopold, Service de Neurochirurgie
Phase 3 Study of Fibrocaps™ in Surgical Bleeding
Flemish Brabant : Research Site
Long-Term Safety and Efficacy of Recombinant Human Coagulation Factor IX Fusion Protein (rFIXFc) in the Prevention and Treatment of Bleeding Episodes in Previously Treated Subjects With Hemophilia B
Gent : Universitair Ziekenhuis Gent, Gasto-Intestinale Heelkunde
Phase 3 Study of Fibrocaps™ in Surgical Bleeding
Leuven :
A Premarket, Prospective, Randomized, Single-Blind Study to Compare the Veriset™ Hemostatic Patch to TachoSil® as an Adjunct to Hemostasis in Subjects Undergoing Cardiovascular Surgery
Leuven : UZ Leuven
Pharmacokinetics, Safety and Efficacy of Recombinant Von Willebrand Factor (rVWF) in the Treatment of Bleeding Episodes in Von Willebrand Disease (VWD)
Leuven : Universitair Ziekenhuis Leuven, Abdominale Heelkunde
Phase 3 Study of Fibrocaps™ in Surgical Bleeding
Brazil
Campinas :
Evaluation of Safety and Efficacy, Including Pharmacokinetics, of NNC 0129-0000-1003 When Administered for Treatment and Prophylaxis of Bleeding in Subjects With Haemophilia A
Campinas :
Safety and Efficacy of NNC 0155-0000-0004 in Prevention and Treatment of Bleeds in Previously Untreated Children With Haemophilia A
Campinas Sao Paulo : Research Site
Long-Term Safety and Efficacy of Recombinant Human Coagulation Factor IX Fusion Protein (rFIXFc) in the Prevention and Treatment of Bleeding Episodes in Previously Treated Subjects With Hemophilia B
Bulgaria
Sofia : Specialized Haematological Hospital "Joan Pavel"
Pharmacokinetics, Safety and Efficacy of Recombinant Von Willebrand Factor (rVWF) in the Treatment of Bleeding Episodes in Von Willebrand Disease (VWD)
Sofia :
Safety and Efficacy of NNC-0156-0000-0009 After Long-Term Exposure in Patients With Haemophilia B: An Extension to Trials NN7999-3747 and NN7999-3773
Varna : Multiprofile Hospital for Active Treatment "Sveta Marina"
Pharmacokinetics, Safety and Efficacy of Recombinant Von Willebrand Factor (rVWF) in the Treatment of Bleeding Episodes in Von Willebrand Disease (VWD)
Canada
Edmonton : University of Alberta
Clot Lysis: Evaluating Accelerated Resolution of Intraventricular Hemorrhage Phase III
Halifax : Queen Elizabeth II Health Sciences Centre
Hemostasis of Active Gastrointestinal (GI) Luminal Tract Bleeding
Hamilton : Hamilton Health Science
Study of Fibrinogen Concentrate (Human) (FCH) to Control Bleeding During Complex Cardiovascular Surgery
London : London University Health Sciences Centre
Clot Lysis: Evaluating Accelerated Resolution of Intraventricular Hemorrhage Phase III
Montreal : Montreal Neurological Institute at McGill University
Clot Lysis: Evaluating Accelerated Resolution of Intraventricular Hemorrhage Phase III
View More »
Montreal : McGill University Health Center
Hemostasis of Active Gastrointestinal (GI) Luminal Tract Bleeding
Montreal : Royal Victoria Hospital
Safety and Efficacy Study of Fibrin Sealant Grifols Evaluated as an Adjunct to Hemostasis
Montreal : Jewish General Hospital
Safety and Efficacy Study of Fibrin Sealant Grifols Evaluated as an Adjunct to Hemostasis
Toronto :
Safety, Efficacy and Pharmacokinetics of NNC-0156-0000-0009 in Previously Treated Children With Haemophilia B
Toronto : Toronto General Hospital
Study of Fibrinogen Concentrate (Human) (FCH) to Control Bleeding During Complex Cardiovascular Surgery
Toronto : University of Toronto - St. Michael's Hospital
Study of Fibrinogen Concentrate (Human) (FCH) to Control Bleeding During Complex Cardiovascular Surgery
Vancouver : St. Paul's Hospital
Hemostasis of Active Gastrointestinal (GI) Luminal Tract Bleeding
Winnipeg : St. Boniface General Hospital
Safety and Efficacy Study of Fibrin Sealant Grifols Evaluated as an Adjunct to Hemostasis
China
Beijing :
Safety and Efficacy of NNC 0155-0000-0004 in Prevention and Treatment of Bleeds in Previously Untreated Children With Haemophilia A
Beijing : Updated
Study of a 4-phasic Oral Contraceptive for the Treatment of Heavy Menstrual Bleeding
Changchun : Updated
Study of a 4-phasic Oral Contraceptive for the Treatment of Heavy Menstrual Bleeding
Changsha : Updated
Study of a 4-phasic Oral Contraceptive for the Treatment of Heavy Menstrual Bleeding
Chengdu : Updated
Study of a 4-phasic Oral Contraceptive for the Treatment of Heavy Menstrual Bleeding
View More »
Chongqing : Updated
Study of a 4-phasic Oral Contraceptive for the Treatment of Heavy Menstrual Bleeding
Dalian : Updated
Study of a 4-phasic Oral Contraceptive for the Treatment of Heavy Menstrual Bleeding
Guangzhou : Guangzhou Southern Hospital
CavatermTM vs TCRE in Women With DUB
Guangzhou : Zhu Jiang Hospital
CavatermTM vs TCRE in Women With DUB
Hengyang : Updated
Study of a 4-phasic Oral Contraceptive for the Treatment of Heavy Menstrual Bleeding
Jinan : Updated
Study of a 4-phasic Oral Contraceptive for the Treatment of Heavy Menstrual Bleeding
Nanning : Updated
Study of a 4-phasic Oral Contraceptive for the Treatment of Heavy Menstrual Bleeding
Shanghai : Updated
Study of a 4-phasic Oral Contraceptive for the Treatment of Heavy Menstrual Bleeding
Shenyang : Updated
Study of a 4-phasic Oral Contraceptive for the Treatment of Heavy Menstrual Bleeding
Shijiazhuang : Updated
Study of a 4-phasic Oral Contraceptive for the Treatment of Heavy Menstrual Bleeding
Tianjin : Updated
Study of a 4-phasic Oral Contraceptive for the Treatment of Heavy Menstrual Bleeding
Wuhan : Updated
Study of a 4-phasic Oral Contraceptive for the Treatment of Heavy Menstrual Bleeding
Xi'an : Updated
Study of a 4-phasic Oral Contraceptive for the Treatment of Heavy Menstrual Bleeding
Croatia
Zagreb :
Evaluating the Haemostatic Effect of NNC 0129-0000-1003 During Surgical Procedures in Subjects With Haemophilia A
Zagreb :
Evaluation of Safety and Efficacy, Including Pharmacokinetics, of NNC 0129-0000-1003 When Administered for Treatment and Prophylaxis of Bleeding in Subjects With Haemophilia A
Denmark
Århus N :
Evaluation of Safety and Efficacy, Including Pharmacokinetics, of NNC 0129-0000-1003 When Administered for Treatment and Prophylaxis of Bleeding in Subjects With Haemophilia A
Copenhagen : Juliane Marie Centre, Rigshospitalet
Fibrinogen Concentrate as Initial Treatment for Postpartum Haemorrhage: A Randomised Clinically Controlled Trial
Herlev : University Hospital of Herlev
Fibrinogen Concentrate as Initial Treatment for Postpartum Haemorrhage: A Randomised Clinically Controlled Trial
Hilleroed : University Hospital of Hilleroed
Fibrinogen Concentrate as Initial Treatment for Postpartum Haemorrhage: A Randomised Clinically Controlled Trial
Hvidovre : University Hospital of Hvidovre
Fibrinogen Concentrate as Initial Treatment for Postpartum Haemorrhage: A Randomised Clinically Controlled Trial
Egypt
Cairo : Shoubra Maternity Hospital
Study About Patients Using Copper Intrauterine Device
Finland
Helsinki : HUCH Anaestesia and Surgery
Study of Fibrinogen Concentrate (Human) (FCH) to Control Bleeding During Complex Cardiovascular Surgery
France
Alencon : MEROUANI
National Registry of rFVIIa (Novoseven) in Haemorrhagic Traumatology
Amiens : LAIGLE
National Registry of rFVIIa (Novoseven) in Haemorrhagic Traumatology
Annecy : SANTRE
National Registry of rFVIIa (Novoseven) in Haemorrhagic Traumatology
Bordeaux : MOREL
National Registry of rFVIIa (Novoseven) in Haemorrhagic Traumatology
Bourg En Bresse : SEDILLOT
National Registry of rFVIIa (Novoseven) in Haemorrhagic Traumatology
View More »
Brest : HIA Clermont-Tonnerre
Efficacy of the Association Mechanical Prophylaxis + Anticoagulant Prophylaxis on Venous Thromboembolism Incidence in Intensive Care Unit (ICU)
Brest : Medical Intensive Care Unit
Efficacy of the Association Mechanical Prophylaxis + Anticoagulant Prophylaxis on Venous Thromboembolism Incidence in Intensive Care Unit (ICU)
Caen : BULEON
National Registry of rFVIIa (Novoseven) in Haemorrhagic Traumatology
Chambery : MIQUET
National Registry of rFVIIa (Novoseven) in Haemorrhagic Traumatology
Clamart : DEBIEN
National Registry of rFVIIa (Novoseven) in Haemorrhagic Traumatology
Clermont Ferrand : GUELON
National Registry of rFVIIa (Novoseven) in Haemorrhagic Traumatology
Clichy : PEASE
National Registry of rFVIIa (Novoseven) in Haemorrhagic Traumatology
Creteil : COOK
National Registry of rFVIIa (Novoseven) in Haemorrhagic Traumatology
Dijon : NADJI
National Registry of rFVIIa (Novoseven) in Haemorrhagic Traumatology
GAP : Vinsiniti
National Registry of rFVIIa (Novoseven) in Haemorrhagic Traumatology
Grenoble : DECLETY
National Registry of rFVIIa (Novoseven) in Haemorrhagic Traumatology
Kremlin-Bicêtre :
Evaluation of Safety and Efficacy, Including Pharmacokinetics, of NNC 0129-0000-1003 When Administered for Treatment and Prophylaxis of Bleeding in Subjects With Haemophilia A
Kremlin-Bicêtre :
Safety and Efficacy of NNC-0156-0000-0009 After Long-Term Exposure in Patients With Haemophilia B: An Extension to Trials NN7999-3747 and NN7999-3773
Le Kremlin Bicetre : Duranteau
National Registry of rFVIIa (Novoseven) in Haemorrhagic Traumatology
Lille : Medical Intensive Care Unit
Efficacy of the Association Mechanical Prophylaxis + Anticoagulant Prophylaxis on Venous Thromboembolism Incidence in Intensive Care Unit (ICU)
Lille : GARRIGUE
National Registry of rFVIIa (Novoseven) in Haemorrhagic Traumatology
Lyon :
Efficacy and Safety of NNC-0156-0000-0009 During Surgical Procedures in Subjects With Haemophilia B
Lyon : FLOCARD
National Registry of rFVIIa (Novoseven) in Haemorrhagic Traumatology
Marseille : Research Site
Long-Term Safety and Efficacy of Recombinant Human Coagulation Factor IX Fusion Protein (rFIXFc) in the Prevention and Treatment of Bleeding Episodes in Previously Treated Subjects With Hemophilia B
Marseille : GARCIN
National Registry of rFVIIa (Novoseven) in Haemorrhagic Traumatology
Metz : FAVIER
National Registry of rFVIIa (Novoseven) in Haemorrhagic Traumatology
Montpellier : CHARBIT
National Registry of rFVIIa (Novoseven) in Haemorrhagic Traumatology
Montpellier : YUNG
National Registry of rFVIIa (Novoseven) in Haemorrhagic Traumatology
Nancy : AUDIBERT
National Registry of rFVIIa (Novoseven) in Haemorrhagic Traumatology
Nantes : CHUPIN
National Registry of rFVIIa (Novoseven) in Haemorrhagic Traumatology
Nice : ICHAI
National Registry of rFVIIa (Novoseven) in Haemorrhagic Traumatology
Nimes : LEFRANT
National Registry of rFVIIa (Novoseven) in Haemorrhagic Traumatology
Paris : Medical Intensive Care Unit
Efficacy of the Association Mechanical Prophylaxis + Anticoagulant Prophylaxis on Venous Thromboembolism Incidence in Intensive Care Unit (ICU)
Paris :
Evaluating the Haemostatic Effect of NNC 0129-0000-1003 During Surgical Procedures in Subjects With Haemophilia A
Paris : JOURNOIS
National Registry of rFVIIa (Novoseven) in Haemorrhagic Traumatology
Paris : LANGERON
National Registry of rFVIIa (Novoseven) in Haemorrhagic Traumatology
Paris : Mateo A Loris
National Registry of rFVIIa (Novoseven) in Haemorrhagic Traumatology
Pierre Benite : DAVID
National Registry of rFVIIa (Novoseven) in Haemorrhagic Traumatology
Poitiers : Nanadoumgar
National Registry of rFVIIa (Novoseven) in Haemorrhagic Traumatology
Reims : LEPOUSE
National Registry of rFVIIa (Novoseven) in Haemorrhagic Traumatology
Rennes : Bleichner
National Registry of rFVIIa (Novoseven) in Haemorrhagic Traumatology
Rouen : GUITARD
National Registry of rFVIIa (Novoseven) in Haemorrhagic Traumatology
Saint Etienne : MARTIN
National Registry of rFVIIa (Novoseven) in Haemorrhagic Traumatology
Strasbourg : FREYS
National Registry of rFVIIa (Novoseven) in Haemorrhagic Traumatology
Toulon : MEAUDRE
National Registry of rFVIIa (Novoseven) in Haemorrhagic Traumatology
Toulouse : Service de neurologie
Amyloid Imaging and Cognitive Impairment After Intracerebral Hemorrhage
Toulouse : OLIVIER
National Registry of rFVIIa (Novoseven) in Haemorrhagic Traumatology
Vannes : LEBAS
National Registry of rFVIIa (Novoseven) in Haemorrhagic Traumatology
Villefranche Sur Saone : JAULT
National Registry of rFVIIa (Novoseven) in Haemorrhagic Traumatology
Germany
Bad Abbach : Department of Orthopedic Surgery
Use of Etoricoxib Compared to Diclofenac in the Perioperative Treatment of Patients After Total Hip Arthroplasty
Berlin :
Investigation of the Pharmacokinetics of Turoctocog Alfa in Subjects With Haemophilia A
Berlin : Vivantes Klinikum im Friedrichshain
Pharmacokinetics, Safety and Efficacy of Recombinant Von Willebrand Factor (rVWF) in the Treatment of Bleeding Episodes in Von Willebrand Disease (VWD)
Bonn :
Evaluating the Haemostatic Effect of NNC 0129-0000-1003 During Surgical Procedures in Subjects With Haemophilia A
Bonn : Research Site
Long-Term Safety and Efficacy of Recombinant Human Coagulation Factor IX Fusion Protein (rFIXFc) in the Prevention and Treatment of Bleeding Episodes in Previously Treated Subjects With Hemophilia B
View More »
Bonn :
Safety and Efficacy of NNC-0156-0000-0009 After Long-Term Exposure in Patients With Haemophilia B: An Extension to Trials NN7999-3747 and NN7999-3773
Duisburg : Gerinnungszentrum Rhein-Ruhr
Pharmacokinetics, Safety and Efficacy of Recombinant Von Willebrand Factor (rVWF) in the Treatment of Bleeding Episodes in Von Willebrand Disease (VWD)
Erlangen : Department of Neurosurgery, University of Erlangen
Pituitary Functions After Traumatic Brain Injury (TBI) and/or Subarachnoid Hemorrhage (SAH)
Frankfurt am Main : Klinikum der J.-W.-Goethe-Universität
Study of Fibrinogen Concentrate (Human) (FCH) to Control Bleeding During Complex Cardiovascular Surgery
Freiburg :
A Premarket, Prospective, Randomized, Single-Blind Study to Compare the Veriset™ Hemostatic Patch to TachoSil® as an Adjunct to Hemostasis in Subjects Undergoing Cardiovascular Surgery
Halle : University of Halle
Clot Lysis: Evaluating Accelerated Resolution of Intraventricular Hemorrhage Phase III
Hannover :
Efficacy and Safety of NNC-0156-0000-0009 During Surgical Procedures in Subjects With Haemophilia B
Hannover :
Evaluation of Safety and Efficacy, Including Pharmacokinetics, of NNC 0129-0000-1003 When Administered for Treatment and Prophylaxis of Bleeding in Subjects With Haemophilia A
Heidelberg : University of Heidelberg
Clot Lysis: Evaluating Accelerated Resolution of Intraventricular Hemorrhage Phase III
Leipzig : University of Leipzig
Clot Lysis: Evaluating Accelerated Resolution of Intraventricular Hemorrhage Phase III
Mainz : University of Mainz
Clot Lysis: Evaluating Accelerated Resolution of Intraventricular Hemorrhage Phase III
Mainz : Universitätsmedizin der Johannes Gutenberg Universität Mainz
Pharmacokinetics, Safety and Efficacy of Recombinant Von Willebrand Factor (rVWF) in the Treatment of Bleeding Episodes in Von Willebrand Disease (VWD)
München : Technischen Universität München
A Prospective, Multi-Center, Single-Arm Study of the Veriset™ Hemostatic Patch in Controlling Bleeding in Soft Tissue
Munich : Klinikum der Universität München
Study of Fibrinogen Concentrate (Human) (FCH) to Control Bleeding During Complex Cardiovascular Surgery
Greece
Athens :
Safety and Efficacy of NNC 0155-0000-0004 in Prevention and Treatment of Bleeds in Previously Untreated Children With Haemophilia A
Hong Kong
Hong Kong : Prince of Wales Hospital
Hemostasis of Active Gastrointestinal (GI) Luminal Tract Bleeding
Hong Kong : Research Site
Long-Term Safety and Efficacy of Recombinant Human Coagulation Factor IX Fusion Protein (rFIXFc) in the Prevention and Treatment of Bleeding Episodes in Previously Treated Subjects With Hemophilia B
Shatin, New Territories :
Safety and Efficacy of NNC 0155-0000-0004 in Prevention and Treatment of Bleeds in Previously Untreated Children With Haemophilia A
Hungary
Debrecen :
Evaluating the Haemostatic Effect of NNC 0129-0000-1003 During Surgical Procedures in Subjects With Haemophilia A
Debrecen :
Evaluation of Safety and Efficacy, Including Pharmacokinetics, of NNC 0129-0000-1003 When Administered for Treatment and Prophylaxis of Bleeding in Subjects With Haemophilia A
India
Karnataka : Research Site
Long-Term Safety and Efficacy of Recombinant Human Coagulation Factor IX Fusion Protein (rFIXFc) in the Prevention and Treatment of Bleeding Episodes in Previously Treated Subjects With Hemophilia B
Maharashtra : Research Site
Long-Term Safety and Efficacy of Recombinant Human Coagulation Factor IX Fusion Protein (rFIXFc) in the Prevention and Treatment of Bleeding Episodes in Previously Treated Subjects With Hemophilia B
Pune : Sahyadri Speciality Hospital
Pharmacokinetics, Safety and Efficacy of Recombinant Von Willebrand Factor (rVWF) in the Treatment of Bleeding Episodes in Von Willebrand Disease (VWD)
Pune : Jehangir Clinical Development Centre Pvt. Ltd.
Pharmacokinetics, Safety and Efficacy of Recombinant Von Willebrand Factor (rVWF) in the Treatment of Bleeding Episodes in Von Willebrand Disease (VWD)
Pune : Sahyadri Specialty Hospital
Wilate in Subjects With Von Willebrand Disease Who Undergo Major Surgery
View More »
Vellore : Christian Medical College
Pharmacokinetics, Safety and Efficacy of Recombinant Von Willebrand Factor (rVWF) in the Treatment of Bleeding Episodes in Von Willebrand Disease (VWD)
Vellore : Christian Medical College
Wilate in Subjects With Von Willebrand Disease Who Undergo Major Surgery
Israel
Beer Sheva : OB\GYN Soroka University Medical Center
Hemcon© Bandage for Postpartum Bleeding Due to the Multiple Vaginal Lacerations
Haifa : Rambam Medical Center
Clot Lysis: Evaluating Accelerated Resolution of Intraventricular Hemorrhage Phase III
Jerusalem : Hadassah Hebrew University Hospital
Clot Lysis: Evaluating Accelerated Resolution of Intraventricular Hemorrhage Phase III
Ramat-Gan : Chaim Sheba Medical Center
Clot Lysis: Evaluating Accelerated Resolution of Intraventricular Hemorrhage Phase III
Tel Aviv : Sourasky Medical Center
Clot Lysis: Evaluating Accelerated Resolution of Intraventricular Hemorrhage Phase III
Italy
Bologna : Policlinico S. Orsola Malpighi
Study of Fibrinogen Concentrate (Human) (FCH) to Control Bleeding During Complex Cardiovascular Surgery
Firenze :
Safety and Efficacy of NNC-0156-0000-0009 After Long-Term Exposure in Patients With Haemophilia B: An Extension to Trials NN7999-3747 and NN7999-3773
Florence : Research Site
Long-Term Safety and Efficacy of Recombinant Human Coagulation Factor IX Fusion Protein (rFIXFc) in the Prevention and Treatment of Bleeding Episodes in Previously Treated Subjects With Hemophilia B
Florence : Azienda Ospedaliera Universitaria Careggi
Pharmacokinetics, Safety and Efficacy of Recombinant Von Willebrand Factor (rVWF) in the Treatment of Bleeding Episodes in Von Willebrand Disease (VWD)
Milano :
Efficacy and Safety of NNC-0156-0000-0009 During Surgical Procedures in Subjects With Haemophilia B
View More »
Milano :
Evaluating the Haemostatic Effect of NNC 0129-0000-1003 During Surgical Procedures in Subjects With Haemophilia A
Milano :
Evaluation of Safety and Efficacy, Including Pharmacokinetics, of NNC 0129-0000-1003 When Administered for Treatment and Prophylaxis of Bleeding in Subjects With Haemophilia A
Milano : Research Site
Long-Term Safety and Efficacy of Recombinant Human Coagulation Factor IX Fusion Protein (rFIXFc) in the Prevention and Treatment of Bleeding Episodes in Previously Treated Subjects With Hemophilia B
Milano : Fondazione IRCCS Cà Granda Ospedale Maggiore Policlinico
Pharmacokinetics, Safety and Efficacy of Recombinant Von Willebrand Factor (rVWF) in the Treatment of Bleeding Episodes in Von Willebrand Disease (VWD)
Milano :
Safety, Efficacy and Pharmacokinetics of NNC-0156-0000-0009 in Previously Treated Children With Haemophilia B
Milano : Fondazione Centro San Raffaele
Study of Fibrinogen Concentrate (Human) (FCH) to Control Bleeding During Complex Cardiovascular Surgery
Milano : Granda Ospedale Maggiore Policlinico
Wilate in Subjects With Von Willebrand Disease Who Undergo Major Surgery
Roma : Università degli Studi di Roma "La Sapienza"
Pharmacokinetics, Safety and Efficacy of Recombinant Von Willebrand Factor (rVWF) in the Treatment of Bleeding Episodes in Von Willebrand Disease (VWD)
Udine : Azienda Ospedaliera di Udine
Study of Fibrinogen Concentrate (Human) (FCH) to Control Bleeding During Complex Cardiovascular Surgery
Vicenza : Ospedale San Bortolo
Pharmacokinetics, Safety and Efficacy of Recombinant Von Willebrand Factor (rVWF) in the Treatment of Bleeding Episodes in Von Willebrand Disease (VWD)
Vicenza : ULSS6 Vicenza Ematologia
Wilate in Subjects With Von Willebrand Disease Who Undergo Major Surgery
Japan
Kasihara-City : Research Site
Long-Term Safety and Efficacy of Recombinant Human Coagulation Factor IX Fusion Protein (rFIXFc) in the Prevention and Treatment of Bleeding Episodes in Previously Treated Subjects With Hemophilia B
Kitakyushu : Research Site
Long-Term Safety and Efficacy of Recombinant Human Coagulation Factor IX Fusion Protein (rFIXFc) in the Prevention and Treatment of Bleeding Episodes in Previously Treated Subjects With Hemophilia B
Miyamae-ku : Research Site
Long-Term Safety and Efficacy of Recombinant Human Coagulation Factor IX Fusion Protein (rFIXFc) in the Prevention and Treatment of Bleeding Episodes in Previously Treated Subjects With Hemophilia B
Nagoya : Research Site
Long-Term Safety and Efficacy of Recombinant Human Coagulation Factor IX Fusion Protein (rFIXFc) in the Prevention and Treatment of Bleeding Episodes in Previously Treated Subjects With Hemophilia B
Shinjuku-ku : Research Site
Long-Term Safety and Efficacy of Recombinant Human Coagulation Factor IX Fusion Protein (rFIXFc) in the Prevention and Treatment of Bleeding Episodes in Previously Treated Subjects With Hemophilia B
View More »
Shinjuku-ku, Tokyo :
Efficacy and Safety of NNC-0156-0000-0009 During Surgical Procedures in Subjects With Haemophilia B
Shinjuku-ku, Tokyo :
Safety and Efficacy of NNC-0156-0000-0009 After Long-Term Exposure in Patients With Haemophilia B: An Extension to Trials NN7999-3747 and NN7999-3773
Shinjuku-ku, Tokyo :
Safety of Monthly Recombinant Factor XIII Replacement Therapy in Subjects With Congenital Factor XIII Deficiency: An Extension to Trial F13CD-1725
Suginami-ku : Research Site
Long-Term Safety and Efficacy of Recombinant Human Coagulation Factor IX Fusion Protein (rFIXFc) in the Prevention and Treatment of Bleeding Episodes in Previously Treated Subjects With Hemophilia B
Suginami-ku, Tokyo :
Evaluation of Safety and Efficacy, Including Pharmacokinetics, of NNC 0129-0000-1003 When Administered for Treatment and Prophylaxis of Bleeding in Subjects With Haemophilia A
Suginami-ku, Tokyo :
Safety, Efficacy and Pharmacokinetics of NNC-0156-0000-0009 in Previously Treated Children With Haemophilia B
Tokyo : Tokyo Medical University Hospital
Pharmacokinetics, Safety and Efficacy of Recombinant Von Willebrand Factor (rVWF) in the Treatment of Bleeding Episodes in Von Willebrand Disease (VWD)
Korea, Republic of
Ansan : Korea University Ansan Hospital
PreventIon of CArdiovascular Events in iSchemic Stroke Patients With High Risk of Cerebral HemOrrhage
Anyang : Hallym University Sacred Heart Hospital
PreventIon of CArdiovascular Events in iSchemic Stroke Patients With High Risk of Cerebral HemOrrhage
Bucheon : Soonchunhyang University Bucheon Hospital
PreventIon of CArdiovascular Events in iSchemic Stroke Patients With High Risk of Cerebral HemOrrhage
Busan : Pusan National University Hospital
PreventIon of CArdiovascular Events in iSchemic Stroke Patients With High Risk of Cerebral HemOrrhage
Busan : Dong-A University Hospital
PreventIon of CArdiovascular Events in iSchemic Stroke Patients With High Risk of Cerebral HemOrrhage
View More »
Busan : Inje Univercity Heaundae Paik Hospital
PreventIon of CArdiovascular Events in iSchemic Stroke Patients With High Risk of Cerebral HemOrrhage
Busan : Inje University Pusan Paik Hospital
PreventIon of CArdiovascular Events in iSchemic Stroke Patients With High Risk of Cerebral HemOrrhage
Busan : Kosin University Gospel Hospital
PreventIon of CArdiovascular Events in iSchemic Stroke Patients With High Risk of Cerebral HemOrrhage
Changwon : Samsung changwon Medical Center
PreventIon of CArdiovascular Events in iSchemic Stroke Patients With High Risk of Cerebral HemOrrhage
Changwon : Chang Won Fatima hospital
PreventIon of CArdiovascular Events in iSchemic Stroke Patients With High Risk of Cerebral HemOrrhage
Cheonan : Soonchunhyang University Cheonan Hospital
PreventIon of CArdiovascular Events in iSchemic Stroke Patients With High Risk of Cerebral HemOrrhage
Cheongju : Chungbuk National University Hospital
PreventIon of CArdiovascular Events in iSchemic Stroke Patients With High Risk of Cerebral HemOrrhage
Chuncheon : Kangwon National University Hospital
PreventIon of CArdiovascular Events in iSchemic Stroke Patients With High Risk of Cerebral HemOrrhage
Daegu : Keimyung University Dongsan Center
PreventIon of CArdiovascular Events in iSchemic Stroke Patients With High Risk of Cerebral HemOrrhage
Daegu : Daegu Fatima Hospital
PreventIon of CArdiovascular Events in iSchemic Stroke Patients With High Risk of Cerebral HemOrrhage
Daejeon :
Evaluating the Haemostatic Effect of NNC 0129-0000-1003 During Surgical Procedures in Subjects With Haemophilia A
Daejeon :
Evaluation of Safety and Efficacy, Including Pharmacokinetics, of NNC 0129-0000-1003 When Administered for Treatment and Prophylaxis of Bleeding in Subjects With Haemophilia A
Daejon : Eulji University Hospital
PreventIon of CArdiovascular Events in iSchemic Stroke Patients With High Risk of Cerebral HemOrrhage
Deagu : Kyungpook National University Hospital
PreventIon of CArdiovascular Events in iSchemic Stroke Patients With High Risk of Cerebral HemOrrhage
Deagu : Yeungnam University Medical Center
PreventIon of CArdiovascular Events in iSchemic Stroke Patients With High Risk of Cerebral HemOrrhage
Deagu : Dongsan Medical Center
PreventIon of CArdiovascular Events in iSchemic Stroke Patients With High Risk of Cerebral HemOrrhage
Deagu : Deagu Catholic University Hospital
PreventIon of CArdiovascular Events in iSchemic Stroke Patients With High Risk of Cerebral HemOrrhage
Deajeon : Deajeon St.Mary's Hospital, The Catholic University of Korea
PreventIon of CArdiovascular Events in iSchemic Stroke Patients With High Risk of Cerebral HemOrrhage
Deajeon : Chungnam National University Hospital
PreventIon of CArdiovascular Events in iSchemic Stroke Patients With High Risk of Cerebral HemOrrhage
Goyang : Inje University Ilsan Paik Hospital
PreventIon of CArdiovascular Events in iSchemic Stroke Patients With High Risk of Cerebral HemOrrhage
Goyang : Dongguk University International Hospital
PreventIon of CArdiovascular Events in iSchemic Stroke Patients With High Risk of Cerebral HemOrrhage
Goyang-si : National Health Insurance Corporation Ilsan Hoapital
PreventIon of CArdiovascular Events in iSchemic Stroke Patients With High Risk of Cerebral HemOrrhage
Guri : Hanyang University Guri Hospital
PreventIon of CArdiovascular Events in iSchemic Stroke Patients With High Risk of Cerebral HemOrrhage
GwangJu : Chosun University Hospital
PreventIon of CArdiovascular Events in iSchemic Stroke Patients With High Risk of Cerebral HemOrrhage
Gwangju : Chonnam National University Hospital
PreventIon of CArdiovascular Events in iSchemic Stroke Patients With High Risk of Cerebral HemOrrhage
Gyeonggi-do : Kwandong University College of Medicine Myongji Hospital
PreventIon of CArdiovascular Events in iSchemic Stroke Patients With High Risk of Cerebral HemOrrhage
Iksan : Wonkwang University Hospital
PreventIon of CArdiovascular Events in iSchemic Stroke Patients With High Risk of Cerebral HemOrrhage
Incheon : Gachon University Gil Hoapital
PreventIon of CArdiovascular Events in iSchemic Stroke Patients With High Risk of Cerebral HemOrrhage
Inchon : Inha University Hospital
PreventIon of CArdiovascular Events in iSchemic Stroke Patients With High Risk of Cerebral HemOrrhage
Jeonju-si : Chonbuk National University Hospital
PreventIon of CArdiovascular Events in iSchemic Stroke Patients With High Risk of Cerebral HemOrrhage
Jinju : Gyeongsang National University Hospital
PreventIon of CArdiovascular Events in iSchemic Stroke Patients With High Risk of Cerebral HemOrrhage
Pusan : Wallace Memorial Baptist Hospital
PreventIon of CArdiovascular Events in iSchemic Stroke Patients With High Risk of Cerebral HemOrrhage
Seongnam : Seoul National University Bundang Hospital
PreventIon of CArdiovascular Events in iSchemic Stroke Patients With High Risk of Cerebral HemOrrhage
Seongnam-si : Bundang Medical Center, CHA University
PreventIon of CArdiovascular Events in iSchemic Stroke Patients With High Risk of Cerebral HemOrrhage
Seoul : Gangnam Severance Hospital
PreventIon of CArdiovascular Events in iSchemic Stroke Patients With High Risk of Cerebral HemOrrhage
Seoul : Kangdong Sacred Heart Hospital, Hallym University
PreventIon of CArdiovascular Events in iSchemic Stroke Patients With High Risk of Cerebral HemOrrhage
Seoul : Ewha Womans University Medical Center
PreventIon of CArdiovascular Events in iSchemic Stroke Patients With High Risk of Cerebral HemOrrhage
Seoul : National Medical Center
PreventIon of CArdiovascular Events in iSchemic Stroke Patients With High Risk of Cerebral HemOrrhage
Seoul : Seoul National University Borame Hospital
PreventIon of CArdiovascular Events in iSchemic Stroke Patients With High Risk of Cerebral HemOrrhage
Seoul : Konkuk Univ. Hospital
PreventIon of CArdiovascular Events in iSchemic Stroke Patients With High Risk of Cerebral HemOrrhage
Seoul : Asan Medical Center
PreventIon of CArdiovascular Events in iSchemic Stroke Patients With High Risk of Cerebral HemOrrhage
Seoul : Seoul Medical Center
PreventIon of CArdiovascular Events in iSchemic Stroke Patients With High Risk of Cerebral HemOrrhage
Seoul : Seoul National University Hospital
PreventIon of CArdiovascular Events in iSchemic Stroke Patients With High Risk of Cerebral HemOrrhage
Seoul : Seoul St.Mary's Hospital
PreventIon of CArdiovascular Events in iSchemic Stroke Patients With High Risk of Cerebral HemOrrhage
Seoul : Severance Hospital
PreventIon of CArdiovascular Events in iSchemic Stroke Patients With High Risk of Cerebral HemOrrhage
Seoul : Soonchunhyang University Hospital
PreventIon of CArdiovascular Events in iSchemic Stroke Patients With High Risk of Cerebral HemOrrhage
Seoul : St. Mary's Hospital
PreventIon of CArdiovascular Events in iSchemic Stroke Patients With High Risk of Cerebral HemOrrhage
Seoul : Chung-Ang University Medical Center
PreventIon of CArdiovascular Events in iSchemic Stroke Patients With High Risk of Cerebral HemOrrhage
Seoul : Eulji Hospital
PreventIon of CArdiovascular Events in iSchemic Stroke Patients With High Risk of Cerebral HemOrrhage
Seoul : Hangang Sacred Heart Hospital
PreventIon of CArdiovascular Events in iSchemic Stroke Patients With High Risk of Cerebral HemOrrhage
Seoul : Hanyang University Medical Center
PreventIon of CArdiovascular Events in iSchemic Stroke Patients With High Risk of Cerebral HemOrrhage
Seoul : Inje University Sanggye Paik Hospital
PreventIon of CArdiovascular Events in iSchemic Stroke Patients With High Risk of Cerebral HemOrrhage
Seoul : Kangbuk Samsung Hospital
PreventIon of CArdiovascular Events in iSchemic Stroke Patients With High Risk of Cerebral HemOrrhage
Seoul : Kangnam Sacred Heart Hospital, Hallym University College of Medicine
PreventIon of CArdiovascular Events in iSchemic Stroke Patients With High Risk of Cerebral HemOrrhage
Seoul : Korea University Anam Hospital
PreventIon of CArdiovascular Events in iSchemic Stroke Patients With High Risk of Cerebral HemOrrhage
Seoul : Korea University Guro Hospital
PreventIon of CArdiovascular Events in iSchemic Stroke Patients With High Risk of Cerebral HemOrrhage
Seoul : Kyung Hee University Medical Center
PreventIon of CArdiovascular Events in iSchemic Stroke Patients With High Risk of Cerebral HemOrrhage
Suwon : Ajou University Hospital
PreventIon of CArdiovascular Events in iSchemic Stroke Patients With High Risk of Cerebral HemOrrhage
Uijeongbu : Uijeongbu St. Mary's Hospital
PreventIon of CArdiovascular Events in iSchemic Stroke Patients With High Risk of Cerebral HemOrrhage
Ulsan : Ulsan University Hospital
PreventIon of CArdiovascular Events in iSchemic Stroke Patients With High Risk of Cerebral HemOrrhage
Wonju : Wonju Christian Hospital
PreventIon of CArdiovascular Events in iSchemic Stroke Patients With High Risk of Cerebral HemOrrhage
Latvia
Riga :
Investigation of the Pharmacokinetics of Turoctocog Alfa in Subjects With Haemophilia A
Macedonia, The Former Yugoslav Republic of
Skopje :
Efficacy and Safety of NNC-0156-0000-0009 During Surgical Procedures in Subjects With Haemophilia B
Skopje :
Safety and Efficacy of NNC-0156-0000-0009 After Long-Term Exposure in Patients With Haemophilia B: An Extension to Trials NN7999-3747 and NN7999-3773
Malaysia
Kuala Lumpur :
Evaluation of Safety and Efficacy, Including Pharmacokinetics, of NNC 0129-0000-1003 When Administered for Treatment and Prophylaxis of Bleeding in Subjects With Haemophilia A
Kuala Lumpur :
Safety and Efficacy of NNC-0156-0000-0009 After Long-Term Exposure in Patients With Haemophilia B: An Extension to Trials NN7999-3747 and NN7999-3773
Kuala Lumpur :
Safety, Efficacy and Pharmacokinetics of NNC-0156-0000-0009 in Previously Treated Children With Haemophilia B
Selangor Darul Ehsan :
Evaluating the Haemostatic Effect of NNC 0129-0000-1003 During Surgical Procedures in Subjects With Haemophilia A
Netherlands
Breda : Amphia Hospital
Phase 3 Study of Fibrocaps™ in Surgical Bleeding
Enschede : Medisch Spectrum Twente
Phase 3 Study of Fibrocaps™ in Surgical Bleeding
Groningen :
Evaluating the Haemostatic Effect of NNC 0129-0000-1003 During Surgical Procedures in Subjects With Haemophilia A
Groningen :
Evaluation of Safety and Efficacy, Including Pharmacokinetics, of NNC 0129-0000-1003 When Administered for Treatment and Prophylaxis of Bleeding in Subjects With Haemophilia A
Groningen : University Medical Centre Groningen
Phase 3 Study of Fibrocaps™ in Surgical Bleeding
View More »
Leiden : Leiden University Medical Center
Phase 3 Study of Fibrocaps™ in Surgical Bleeding
Nijmegen : Radboud University Medical Center
Phase 3 Study of Fibrocaps™ in Surgical Bleeding
Rotterdam : Erasmus MC
Pharmacokinetics, Safety and Efficacy of Recombinant Von Willebrand Factor (rVWF) in the Treatment of Bleeding Episodes in Von Willebrand Disease (VWD)
Rotterdam : Erasmus Medical Center
Phase 3 Study of Fibrocaps™ in Surgical Bleeding
Utrecht :
Efficacy and Safety of NNC-0156-0000-0009 During Surgical Procedures in Subjects With Haemophilia B
Utrecht :
Safety and Efficacy of NNC-0156-0000-0009 After Long-Term Exposure in Patients With Haemophilia B: An Extension to Trials NN7999-3747 and NN7999-3773
Velp : Rijnstate Arnhem
Phase 3 Study of Fibrocaps™ in Surgical Bleeding
Norway
Oslo :
Evaluating the Haemostatic Effect of NNC 0129-0000-1003 During Surgical Procedures in Subjects With Haemophilia A
Oslo :
Evaluation of Safety and Efficacy, Including Pharmacokinetics, of NNC 0129-0000-1003 When Administered for Treatment and Prophylaxis of Bleeding in Subjects With Haemophilia A
Pakistan
Karachi, Sindh : Site Reference ID/Investigator# 77680 Updated
Severity of Bleeding as a Predictor of Quality of Life (QoL) in Women With Heavy Menstrual Bleeding (HMB) Under Dydrogesterone Treatment
Karachi, Sindh : Site Reference ID/Investigator# 77681 Updated
Severity of Bleeding as a Predictor of Quality of Life (QoL) in Women With Heavy Menstrual Bleeding (HMB) Under Dydrogesterone Treatment
Karachi, Sindh : Site Reference ID/Investigator# 77674 Updated
Severity of Bleeding as a Predictor of Quality of Life (QoL) in Women With Heavy Menstrual Bleeding (HMB) Under Dydrogesterone Treatment
Karachi, Sindh : Site Reference ID/Investigator# 77675 Updated
Severity of Bleeding as a Predictor of Quality of Life (QoL) in Women With Heavy Menstrual Bleeding (HMB) Under Dydrogesterone Treatment
Karachi, Sindh : Site Reference ID/Investigator# 77677 Updated
Severity of Bleeding as a Predictor of Quality of Life (QoL) in Women With Heavy Menstrual Bleeding (HMB) Under Dydrogesterone Treatment
View More »
Lahore, Punjab : Site Reference ID/Investigator# 77691 Updated
Severity of Bleeding as a Predictor of Quality of Life (QoL) in Women With Heavy Menstrual Bleeding (HMB) Under Dydrogesterone Treatment
Lahore, Punjab : Site Reference ID/Investigator# 77695 Updated
Severity of Bleeding as a Predictor of Quality of Life (QoL) in Women With Heavy Menstrual Bleeding (HMB) Under Dydrogesterone Treatment
Lahore, Punjab : Site Reference ID/Investigator# 77696 Updated
Severity of Bleeding as a Predictor of Quality of Life (QoL) in Women With Heavy Menstrual Bleeding (HMB) Under Dydrogesterone Treatment
Lahore, Punjab : Site Reference ID/Investigator# 77699 Updated
Severity of Bleeding as a Predictor of Quality of Life (QoL) in Women With Heavy Menstrual Bleeding (HMB) Under Dydrogesterone Treatment
Multan, Punjab : Site Reference ID/Investigator# 77684 Updated
Severity of Bleeding as a Predictor of Quality of Life (QoL) in Women With Heavy Menstrual Bleeding (HMB) Under Dydrogesterone Treatment
Multan, Punjab : Site Reference ID/Investigator# 77686 Updated
Severity of Bleeding as a Predictor of Quality of Life (QoL) in Women With Heavy Menstrual Bleeding (HMB) Under Dydrogesterone Treatment
Multan, Punjab : Site Reference ID/Investigator# 77687 Updated
Severity of Bleeding as a Predictor of Quality of Life (QoL) in Women With Heavy Menstrual Bleeding (HMB) Under Dydrogesterone Treatment
Multan, Punjab : Site Reference ID/Investigator# 77689 Updated
Severity of Bleeding as a Predictor of Quality of Life (QoL) in Women With Heavy Menstrual Bleeding (HMB) Under Dydrogesterone Treatment
Panama
Pittsburgh : Research Site
Long-Term Safety and Efficacy of Recombinant Human Coagulation Factor IX Fusion Protein (rFIXFc) in the Prevention and Treatment of Bleeding Episodes in Previously Treated Subjects With Hemophilia B
Philippines
Manila : University of Santo Tomas
PreventIon of CArdiovascular Events in iSchemic Stroke Patients With High Risk of Cerebral HemOrrhage
Manila : Manila Doctors Hospital
PreventIon of CArdiovascular Events in iSchemic Stroke Patients With High Risk of Cerebral HemOrrhage
Pasig : The Medical City
PreventIon of CArdiovascular Events in iSchemic Stroke Patients With High Risk of Cerebral HemOrrhage
Quezon City : St. Luke's Medical Center
PreventIon of CArdiovascular Events in iSchemic Stroke Patients With High Risk of Cerebral HemOrrhage
Poland
Gdansk : Uniweryteckie Centrum Kliniczne
Wilate in Subjects With Von Willebrand Disease Who Undergo Major Surgery
Lodz : Research Site
Long-Term Safety and Efficacy of Recombinant Human Coagulation Factor IX Fusion Protein (rFIXFc) in the Prevention and Treatment of Bleeding Episodes in Previously Treated Subjects With Hemophilia B
Warsaw : Institute of Haematology and Transfusion Medicine
Pharmacokinetics, Safety and Efficacy of Recombinant Von Willebrand Factor (rVWF) in the Treatment of Bleeding Episodes in Von Willebrand Disease (VWD)
Puerto Rico
San Juan : Puerto Rico Medical Center
Clot Lysis: Evaluating Accelerated Resolution of Intraventricular Hemorrhage Phase III
San Juan : Novo Nordisk Clinical Trial Call Center
Evaluating the Haemostatic Effect of NNC 0129-0000-1003 During Surgical Procedures in Subjects With Haemophilia A
San Juan : Novo Nordisk Clinical Trial Call Center
Evaluation of Safety and Efficacy, Including Pharmacokinetics, of NNC 0129-0000-1003 When Administered for Treatment and Prophylaxis of Bleeding in Subjects With Haemophilia A
San Juan : Novo Nordisk Clinical Trial Call Center
Safety and Efficacy of NNC 0155-0000-0004 in Prevention and Treatment of Bleeds in Previously Untreated Children With Haemophilia A
Russian Federation
Irkutsk : Updated
Study of a 4-phasic Oral Contraceptive for the Treatment of Heavy Menstrual Bleeding
Krasnodar : Updated
Study of a 4-phasic Oral Contraceptive for the Treatment of Heavy Menstrual Bleeding
Saint-Petersburg :
Evaluation of Safety and Efficacy, Including Pharmacokinetics, of NNC 0129-0000-1003 When Administered for Treatment and Prophylaxis of Bleeding in Subjects With Haemophilia A
Saint-Petersburg :
Safety and Efficacy of NNC 0155-0000-0004 in Prevention and Treatment of Bleeds in Previously Untreated Children With Haemophilia A
Saint-Petersburg :
Safety and Efficacy of NNC-0156-0000-0009 After Long-Term Exposure in Patients With Haemophilia B: An Extension to Trials NN7999-3747 and NN7999-3773
South Africa
Cape Town : Research Site
Long-Term Safety and Efficacy of Recombinant Human Coagulation Factor IX Fusion Protein (rFIXFc) in the Prevention and Treatment of Bleeding Episodes in Previously Treated Subjects With Hemophilia B
Johannesburg : Research Site
Long-Term Safety and Efficacy of Recombinant Human Coagulation Factor IX Fusion Protein (rFIXFc) in the Prevention and Treatment of Bleeding Episodes in Previously Treated Subjects With Hemophilia B
Johannesburg : Hemophilia Comprehensive Care Center
Wilate in Subjects With Von Willebrand Disease Who Undergo Major Surgery
Parktown Johannesburg :
Efficacy and Safety of NNC-0156-0000-0009 During Surgical Procedures in Subjects With Haemophilia B
Parktown Johannesburg :
Safety and Efficacy of NNC-0156-0000-0009 After Long-Term Exposure in Patients With Haemophilia B: An Extension to Trials NN7999-3747 and NN7999-3773
Spain
Barcelona : Vall d'Hebron University Hospital
Clot Lysis: Evaluating Accelerated Resolution of Intraventricular Hemorrhage Phase III
Barcelona : Bellvitge Hospital
Clot Lysis: Evaluating Accelerated Resolution of Intraventricular Hemorrhage Phase III
Barcelona : Hospital de la Santa Creu i Sant Pau
Clot Lysis: Evaluating Accelerated Resolution of Intraventricular Hemorrhage Phase III
Barcelona : Hospital Clinic i Provincial
Safety and Efficacy Study of Fibrin Sealant Grifols Evaluated as an Adjunct to Hemostasis
Barcelona : Hospital de Sabadell
Safety and Efficacy Study of Fibrin Sealant Grifols Evaluated as an Adjunct to Hemostasis
View More »
Getafe : Hospital Universitario de Getafe
Safety and Efficacy Study of Fibrin Sealant Grifols Evaluated as an Adjunct to Hemostasis
Madrid :
Efficacy and Safety of NNC-0156-0000-0009 During Surgical Procedures in Subjects With Haemophilia B
Madrid :
Evaluating the Haemostatic Effect of NNC 0129-0000-1003 During Surgical Procedures in Subjects With Haemophilia A
Madrid :
Evaluation of Safety and Efficacy, Including Pharmacokinetics, of NNC 0129-0000-1003 When Administered for Treatment and Prophylaxis of Bleeding in Subjects With Haemophilia A
Madrid :
Investigation of the Pharmacokinetics of Turoctocog Alfa in Subjects With Haemophilia A
Madrid :
Safety and Efficacy of NNC 0155-0000-0004 in Prevention and Treatment of Bleeds in Previously Untreated Children With Haemophilia A
Madrid :
Safety and Efficacy of NNC-0156-0000-0009 After Long-Term Exposure in Patients With Haemophilia B: An Extension to Trials NN7999-3747 and NN7999-3773
Palma de Mallorca : Hospital Son Dureta
Safety and Efficacy Study of Fibrin Sealant Grifols Evaluated as an Adjunct to Hemostasis
Pamplona : Clinica Universitaria de Navarra
Safety and Efficacy Study of Fibrin Sealant Grifols Evaluated as an Adjunct to Hemostasis
Santander : Hospital Universitario Marques de Valdecilla
Safety and Efficacy Study of Fibrin Sealant Grifols Evaluated as an Adjunct to Hemostasis
Sweden
Gothenburg : Sahlgrenska Universitetssjukhuset
Pharmacokinetics, Safety and Efficacy of Recombinant Von Willebrand Factor (rVWF) in the Treatment of Bleeding Episodes in Von Willebrand Disease (VWD)
Malmö :
Evaluating the Haemostatic Effect of NNC 0129-0000-1003 During Surgical Procedures in Subjects With Haemophilia A
Malmö :
Evaluation of Safety and Efficacy, Including Pharmacokinetics, of NNC 0129-0000-1003 When Administered for Treatment and Prophylaxis of Bleeding in Subjects With Haemophilia A
Malmö : Research Site
Long-Term Safety and Efficacy of Recombinant Human Coagulation Factor IX Fusion Protein (rFIXFc) in the Prevention and Treatment of Bleeding Episodes in Previously Treated Subjects With Hemophilia B
Malmoe : Skåne University Hospital (SUS)
Pharmacokinetics, Safety and Efficacy of Recombinant Von Willebrand Factor (rVWF) in the Treatment of Bleeding Episodes in Von Willebrand Disease (VWD)
View More »
Stockholm : Research Site
Long-Term Safety and Efficacy of Recombinant Human Coagulation Factor IX Fusion Protein (rFIXFc) in the Prevention and Treatment of Bleeding Episodes in Previously Treated Subjects With Hemophilia B
Switzerland
Zurich : University of Zurich
Clot Lysis: Evaluating Accelerated Resolution of Intraventricular Hemorrhage Phase III
Zürich :
Evaluating the Haemostatic Effect of NNC 0129-0000-1003 During Surgical Procedures in Subjects With Haemophilia A
Zürich :
Evaluation of Safety and Efficacy, Including Pharmacokinetics, of NNC 0129-0000-1003 When Administered for Treatment and Prophylaxis of Bleeding in Subjects With Haemophilia A
Taiwan
Taipei :
Efficacy and Safety of NNC-0156-0000-0009 During Surgical Procedures in Subjects With Haemophilia B
Taipei :
Evaluating the Haemostatic Effect of NNC 0129-0000-1003 During Surgical Procedures in Subjects With Haemophilia A
Taipei :
Evaluation of Safety and Efficacy, Including Pharmacokinetics, of NNC 0129-0000-1003 When Administered for Treatment and Prophylaxis of Bleeding in Subjects With Haemophilia A
Taipei :
Safety and Efficacy of NNC-0156-0000-0009 After Long-Term Exposure in Patients With Haemophilia B: An Extension to Trials NN7999-3747 and NN7999-3773
Taipei :
Safety, Efficacy and Pharmacokinetics of NNC-0156-0000-0009 in Previously Treated Children With Haemophilia B
View More »
Taipei : Updated
Study of a 4-phasic Oral Contraceptive for the Treatment of Heavy Menstrual Bleeding
Thailand
Bangkok :
Safety and Efficacy of NNC-0156-0000-0009 After Long-Term Exposure in Patients With Haemophilia B: An Extension to Trials NN7999-3747 and NN7999-3773
Bangkok : Updated
Study of a 4-phasic Oral Contraceptive for the Treatment of Heavy Menstrual Bleeding
Turkey
Adana :
Evaluation of Safety and Efficacy, Including Pharmacokinetics, of NNC 0129-0000-1003 When Administered for Treatment and Prophylaxis of Bleeding in Subjects With Haemophilia A
Bornova-IZMIR :
Evaluating the Haemostatic Effect of NNC 0129-0000-1003 During Surgical Procedures in Subjects With Haemophilia A
Bornova-IZMIR :
Safety and Efficacy of NNC 0155-0000-0004 in Prevention and Treatment of Bleeds in Previously Untreated Children With Haemophilia A
Kayseri :
Safety and Efficacy of NNC-0156-0000-0009 After Long-Term Exposure in Patients With Haemophilia B: An Extension to Trials NN7999-3747 and NN7999-3773
Konya :
Efficacy and Safety of NNC-0156-0000-0009 During Surgical Procedures in Subjects With Haemophilia B
View More »
Konya :
Safety, Efficacy and Pharmacokinetics of NNC-0156-0000-0009 in Previously Treated Children With Haemophilia B
United Kingdom
Birmingham : Queen Elizabeth Hospital Birmingham
Phase 3 Study of Fibrocaps™ in Surgical Bleeding
Cambridge : Addenbrookes Hospital Vascular Department
Phase 3 Study of Fibrocaps™ in Surgical Bleeding
Cambridge : Papworth Hospital
Study of Fibrinogen Concentrate (Human) (FCH) to Control Bleeding During Complex Cardiovascular Surgery
Cambridgeshire : Research Site
Long-Term Safety and Efficacy of Recombinant Human Coagulation Factor IX Fusion Protein (rFIXFc) in the Prevention and Treatment of Bleeding Episodes in Previously Treated Subjects With Hemophilia B
Cardiff :
Efficacy and Safety of NNC-0156-0000-0009 During Surgical Procedures in Subjects With Haemophilia B
View More »
Doncaster : Doncaster Royal Infirmary
Phase 3 Study of Fibrocaps™ in Surgical Bleeding
Doncaster : Doncaster Royal Infirmary Hospital
Safety and Efficacy Study of Fibrin Sealant Grifols Evaluated as an Adjunct to Hemostasis
Edgbaston : Queen Elizabeth Hospital Birmingham
Safety and Efficacy Study of Fibrin Sealant Grifols Evaluated as an Adjunct to Hemostasis
Edinburgh : Royal Infirmary of Edinburgh
Safety and Efficacy Study of Fibrin Sealant Grifols Evaluated as an Adjunct to Hemostasis
Epsom : South West London Elective Orthopaedic Center
Bipolar Sealer Aquamantys Use in Total Knee Replacement
Frimley : Frimley Park Hospital
Safety and Efficacy Study of Fibrin Sealant Grifols Evaluated as an Adjunct to Hemostasis
Hull : Hull Royal Infirmary
Phase 3 Study of Fibrocaps™ in Surgical Bleeding
Hull : Hull Royal Infirmary
Safety and Efficacy Study of Fibrin Sealant Grifols Evaluated as an Adjunct to Hemostasis
Leeds : Leeds General Infirmary
Phase 3 Study of Fibrocaps™ in Surgical Bleeding
Leeds : Leeds General Infirmary
Safety and Efficacy Study of Fibrin Sealant Grifols Evaluated as an Adjunct to Hemostasis
London :
Efficacy and Safety of NNC-0156-0000-0009 During Surgical Procedures in Subjects With Haemophilia B
London :
Evaluating the Haemostatic Effect of NNC 0129-0000-1003 During Surgical Procedures in Subjects With Haemophilia A
London :
Evaluation of Safety and Efficacy, Including Pharmacokinetics, of NNC 0129-0000-1003 When Administered for Treatment and Prophylaxis of Bleeding in Subjects With Haemophilia A
London : Research Site
Long-Term Safety and Efficacy of Recombinant Human Coagulation Factor IX Fusion Protein (rFIXFc) in the Prevention and Treatment of Bleeding Episodes in Previously Treated Subjects With Hemophilia B
London : Hammersmith Hospital
Pharmacokinetics, Safety and Efficacy of Recombinant Von Willebrand Factor (rVWF) in the Treatment of Bleeding Episodes in Von Willebrand Disease (VWD)
London : Royal Free Hospital
Pharmacokinetics, Safety and Efficacy of Recombinant Von Willebrand Factor (rVWF) in the Treatment of Bleeding Episodes in Von Willebrand Disease (VWD)
London : The Royal London Hospital
Pharmacokinetics, Safety and Efficacy of Recombinant Von Willebrand Factor (rVWF) in the Treatment of Bleeding Episodes in Von Willebrand Disease (VWD)
London : King's College Hospital
Phase 3 Study of Fibrocaps™ in Surgical Bleeding
London : King's College Hospital NHS Foundation Trust
Preoperative Intravitreal Ranibizumab for Persistent Diabetic Vitreous Haemorrhage:
London :
Safety and Efficacy of NNC-0156-0000-0009 After Long-Term Exposure in Patients With Haemophilia B: An Extension to Trials NN7999-3747 and NN7999-3773
Newcastle upon Tyne : Newcastle General Hospital
Clot Lysis: Evaluating Accelerated Resolution of Intraventricular Hemorrhage Phase III
Newcastle upon Tyne : Freeman Hospital
Phase 3 Study of Fibrocaps™ in Surgical Bleeding
Newcastle upon Tyne : Freeman Hospital
Safety and Efficacy Study of Fibrin Sealant Grifols Evaluated as an Adjunct to Hemostasis
Oxford :
Safety, Efficacy and Pharmacokinetics of NNC-0156-0000-0009 in Previously Treated Children With Haemophilia B
Southampton : University of Southampton Hospital
Clot Lysis: Evaluating Accelerated Resolution of Intraventricular Hemorrhage Phase III
Southampton : Southampton General Hospital
Study of Fibrinogen Concentrate (Human) (FCH) to Control Bleeding During Complex Cardiovascular Surgery
Tooting : St. George's Hospital
Safety and Efficacy Study of Fibrin Sealant Grifols Evaluated as an Adjunct to Hemostasis
Vietnam
Danang : Research Site
Survey of Non-Variceal Upper Gastro Intestinal Bleeding in Vietnamese Patients
Hanoi : Research Site
Survey of Non-Variceal Upper Gastro Intestinal Bleeding in Vietnamese Patients
HoChiMinh City : Research Site
Survey of Non-Variceal Upper Gastro Intestinal Bleeding in Vietnamese Patients
